NewzIntel.com

Category: Science

  • MIL-OSI: Royalty Pharma Reports First Quarter 2025 Results

    Source: GlobeNewswire (MIL-OSI)

    • Portfolio Receipts growth of 17% to $839 million; Royalty Receipts growth of 12%
    • Net cash provided by operating activities of $596 million
    • Raised full year 2025 guidance: Portfolio Receipts expected to be $2,975 to $3,125 million

    NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the first quarter of 2025 and raised full year 2025 guidance for Portfolio Receipts.

    “Our business momentum continued in the first quarter of 2025 as we delivered double-digit growth in Portfolio Receipts and raised our financial guidance,” said Pablo Legorreta, Royalty Pharma’s founder and Chief Executive Officer. “Guided by our dynamic capital allocation framework, we repurchased over $700 million of our Class A ordinary shares given our attractive outlook, we expanded our development-stage portfolio with an R&D funding partnership with Biogen and we again increased our quarterly dividend. Looking ahead, we have strong fundamental tailwinds underpinning our business with a robust deal pipeline and we remain on track to acquire our external manager in the second quarter. We plan to share further details on our attractive long-term outlook at our upcoming Investor Day in September.”

    Double-digit growth in Royalty Receipts and Portfolio Receipts

    • Royalty Receipts grew 12% to $788 million, primarily driven by strong performance from the cystic fibrosis franchise, Trelegy and Xtandi.
    • Portfolio Receipts increased by 17% to $839 million.

    Significant repurchase activity under recently announced $3 billion authorization

    • Repurchased 23 million Class A ordinary shares for $723 million guided by dynamic capital allocation framework.
    • Capital Deployment of $101 million; entered into Phase 3 R&D funding collaboration for Biogen’s litifilimab.
    • Increased quarterly dividend by approximately 5%.

    Positive clinical and regulatory updates across royalty portfolio

    • Johnson & Johnson’s Tremfya received FDA and EC approval in Crohn’s disease, EC approval in ulcerative colitis.
    • Positive Phase 3 results for Emalex’s ecopipam in Tourette syndrome.
    • Roche to initiate a Phase 3 program for trontinemab in Alzheimer’s disease later this year.

    Raised financial guidance for full year 2025 (excludes contribution from future transactions)

    • Royalty Pharma expects 2025 Portfolio Receipts to be between $2,975 million and $3,125 million, representing expected growth of 6% to 12%.
    • The company expects to update 2025 guidance for payments and operating and professional costs and interest paid after the closing of the internalization transaction, which is expected in the second quarter of 2025.

    Financial & Liquidity Summary

      Three Months Ended March 31,
      (unaudited)
    ($ and shares in millions) 2025 2024 Change
    Portfolio Receipts 839 717 17%
    Net cash provided by operating activities 596 665 (10)%
    Adjusted EBITDA (non-GAAP)* 738 656 12%
    Portfolio Cash Flow (non-GAAP)* 611 584 5%
    Weighted average Class A ordinary shares outstanding – diluted 578 597 (3)%

    *See “Liquidity and Capital Resources” section. Adjusted EBITDA and Portfolio Cash Flow are non-GAAP liquidity measures calculated in accordance with the credit agreement.

    Portfolio Receipts Highlights

          Three Months Ended March 31,
          (unaudited)
    ($ in millions)     2025 2024 Change
    Products: Marketers: Therapeutic Area:      
    Cystic fibrosis franchise Vertex Rare disease 250 218 14%
    Trelegy GSK Respiratory 85 71 21%
    Tysabri Biogen Neuroscience 61 69 (12)%
    Evrysdi Roche Rare disease 53 45 17%
    Xtandi Pfizer, Astellas Cancer 52 41 28%
    Imbruvica AbbVie, J&J Cancer 46 50 (8)%
    Promacta Novartis Hematology 44 43 4%
    Tremfya Johnson & Johnson Immunology 36 36 (1)%
    Cabometyx/Cometriq Exelixis, Ipsen, Takeda Cancer 21 18 16%
    Spinraza Biogen Rare disease 13 7 95%
    Trodelvy Gilead Cancer 13 10 23%
    Erleada Johnson & Johnson Cancer 11 9 21%
    Other products(5) 105 88 19%
    Royalty Receipts 788 705 12%
    Milestones and other contractual receipts 51 12 309%
    Portfolio Receipts 839 717 17%

    Amounts shown in the table may not add due to rounding.

    Royalty Receipts was $788 million in the first quarter of 2025, an increase of 12% compared to $705 million in the first quarter of 2024. The increase was primarily driven by strong growth from the cystic fibrosis franchise, Trelegy and Xtandi, as well as royalties from the 2024 launch of Voranigo.

    Portfolio Receipts was $839 million in the first quarter of 2025, an increase of 17% compared to $717 million in the first quarter of 2024, primarily driven by the same Royalty Receipts increases noted above and a milestone payment of $27 million related to Airsupra.

    Liquidity and Capital Resources

    Royalty Pharma’s liquidity and capital resources are summarized below:

    As of March 31, 2025, Royalty Pharma had cash and cash equivalents of $1.1 billion and total debt with principal value of $7.8 billion.

    In January 2025, Royalty Pharma completed the sale of the MorphoSys Development Funding Bonds for $511 million in upfront cash. This payment, combined with quarterly repayments received prior to the sale, resulted in total cash proceeds of $530 million on the $300 million investment that was made in September 2022. The proceeds provide added flexibility to pursue the company’s dynamic capital allocation strategy.

    In January 2025, Royalty Pharma announced a new share repurchase program under which it may repurchase up to $3.0 billion of its Class A ordinary shares. During the first quarter of 2025, Royalty Pharma repurchased approximately 23 million Class A ordinary shares for $723 million. During the first quarter of 2024, Royalty Pharma did not repurchase any Class A ordinary shares. The weighted-average number of diluted Class A ordinary shares outstanding for the first quarter of 2025 was 578 million as compared to 597 million for the first quarter of 2024.

    Liquidity Summary

      Three Months Ended March 31,
      (unaudited)
    ($ in millions) 2025   2024  
    Portfolio Receipts 839   717  
    Payments for operating and professional costs (102)   (61)  
    Adjusted EBITDA (non-GAAP) 738   656  
    Interest paid, net (127)   (73)  
    Portfolio Cash Flow (non-GAAP) 611   584  

    Amounts may not add due to rounding.

    • Adjusted EBITDA (non-GAAP) was $738 million in the first quarter of 2025. Adjusted EBITDA is calculated as Portfolio Receipts minus payments for operating and professional costs. Payments for operating and professional costs for the first quarter of 2025 included a $33 million one-time payment related to the management fee on the sale of the MorphoSys Development Funding Bonds.
    • Portfolio Cash Flow (non-GAAP) was $611 million in the first quarter of 2025. Portfolio Cash Flow is calculated as Adjusted EBITDA minus interest paid or received, net. This measure reflects the cash generated by Royalty Pharma’s business that can be redeployed into value-enhancing royalty acquisitions, used to repay debt, returned to shareholders through dividends or share purchases, or utilized for other discretionary investments.

    Refer to Table 4 for Royalty Pharma’s reconciliation of each non-GAAP measure to the most directly comparable GAAP financial measure, net cash provided by operating activities.

    Capital Deployment reflects cash payments during the period for new and previously announced transactions. Capital Deployment was $101 million in the first quarter of 2025, consisting primarily of the upfront research and development (“R&D”) funding for litifilimab (discussed further below) and a milestone payment related to Trelegy.

    In April 2025, Ferring Pharmaceuticals announced U.S. Food and Drug Administration (“FDA”) approval of a new manufacturing hub in Parsippany, NJ for Adstiladrin, its novel gene therapy for bladder cancer. The approval triggered a $200 million milestone payment that was paid in the second quarter of 2025 as part of the royalty agreement announced in 2023.

    The table below details Capital Deployment by category:

    Capital Deployment

      Three Months Ended March 31,
      (unaudited)
    ($ in millions) 2025   2024  
    Acquisitions of financial royalty assets (1)   (86)  
    Development-stage funding payments (51)   (1)  
    Milestone payments (50)   —  
    Investments in equity method investees —   (7)  
    Contributions from legacy non-controlling interests – R&D 0   0  
    Capital Deployment (101)   (93)  

    Amounts may not add due to rounding.

    Royalty Transactions

    In February 2025, Royalty Pharma entered into an R&D funding arrangement with Biogen to provide up to $250 million over six quarters, including $50 million upfront for the development of litifilimab. Litifilimab is in Phase 3 development for the treatment of lupus. The announced transaction amount reflects the entire amount of capital committed for new transactions during the year, including potential future milestones.

    The information in this section should be read together with Royalty Pharma’s reports and documents filed with the SEC at www.sec.gov and the reader is also encouraged to review all other press releases and information available in the Investors section of Royalty Pharma’s website at www.royaltypharma.com.

    Internalization Transaction

    In January 2025, Royalty Pharma agreed to acquire its external manager, RP Management, LLC (the “Manager”) (press release). This transaction to simplify Royalty Pharma’s corporate structure is expected to result in multiple benefits for shareholders. On a financial basis, the acquisition is expected to reduce costs and enhance economic returns on investments. Specifically, the acquisition will generate cash savings of greater than $100 million in 2026, rising to greater than $175 million in 2030 and driving cumulative savings of greater than $1.6 billion over ten years. The acquisition also increases shareholder alignment, enhances corporate governance, ensures management continuity and simplifies Royalty Pharma’s corporate structure.

    The total transaction value of approximately $1.1 billion(7) consists of approximately 24.5 million shares of Royalty Pharma equity that will vest over five to nine years, approximately $100 million in cash(8), and the assumption of $380 million of the Manager’s existing debt.

    The closing of the internalization transaction is subject to shareholders’ approval of the issuance of the share consideration and other customary closing conditions, including required regulatory approvals. The shareholder meeting will take place on May 12, 2025 and the transaction is estimated to close during the second quarter of 2025.

    Key Developments Relating to the Portfolio

    The key developments related to Royalty Pharma’s royalty interests are discussed below based on disclosures from the marketers of the products.

    Tremfya In May 2025, Johnson & Johnson announced that the European Commission (“EC”) approved Tremfya for the treatment of adult patients with moderately to severely active Crohn’s disease.

    In April 2025, Johnson & Johnson announced that the EC approved Tremfya for the treatment of adult patients with moderately to severely active ulcerative colitis.

    In March 2025, Johnson & Johnson announced that the FDA approved Tremfya, which is now the first and only IL-23 offering both subcutaneous and intravenous induction options for the treatment of adults with moderately to severely active Crohn’s disease.
    aficamten In May 2025, Cytokinetics announced that the FDA has extended the Prescription Drug User Fee Act (PDUFA) action date for the New Drug Application for aficamten to December 26, 2025. The FDA notified Cytokinetics that additional time is required to conduct a full review of the company’s proposed Risk Evaluation and Mitigation Strategy (REMS). No additional clinical data or studies have been requested of Cytokinetics by the FDA.
    Cobenfy In April 2025, Bristol Myers Squibb announced that topline results from the Phase 3 ARISE trial evaluating Cobenfy as an adjunctive treatment to atypical antipsychotics in adults with schizophrenia did not reach the threshold for a statistically significant difference compared to placebo with an atypical antipsychotic for the primary endpoint of the change from baseline to Week 6 in the Positive and Negative Syndrome Scale (PANSS) total score.
    Trodelvy In April 2025, Gilead announced positive topline results from the Phase 3 Ascent-04/Keynote-D19 study, demonstrating that Trodelvy plus Keytruda significantly improved progression-free survival (“PFS”) compared to Keytruda and chemotherapy in patients with previously untreated PD-L1+ metastatic triple-negative breast cancer. Overall survival (“OS”), a key secondary endpoint, was not mature at the time of the PFS primary analysis. However, there was an early trend in improvement for OS with Trodelvy plus Keytruda. Gilead will continue to monitor OS outcomes, with ongoing patient follow-up and further analyses.
    trontinemab In April 2025, Roche announced that new trontinemab data continue to support rapid and deep, dose-dependent reduction of amyloid plaques in Phase 1b/2a Brainshuttle AD study. Roche expects to initiate a Phase 3 program for trontinemab later this year.
    ecopipam In February 2025, Emalex announced positive Phase 3 results for ecopipam in patients with Tourette syndrome. The study showed statistical significance between ecopipam and placebo for both the primary efficacy endpoint in pediatrics and the secondary efficacy endpoint in pediatrics and adults. Emalex will meet with the FDA and other global health authorities to discuss submission later this year of a New Drug Application (“NDA”).
    Spinraza In January 2025, Biogen announced that the FDA accepted the supplemental NDA and the European Medicines Agency validated the application for a higher dose regimen of Spinraza for spinal muscular atrophy.
    TEV-‘749 In January 2025, Teva announced that TEV-’749 (olanzapine LAI) achieved Phase 3 targeted injections without PDSS (post-injection delirium/sedation syndrome), and the full safety presentation is expected in the second quarter of 2025.


    2025 Financial Outlook

    Royalty Pharma has provided guidance for full year 2025, excluding new transactions and borrowings announced after the date of this release, as follows:

      Provided May 8th, 2025 Previous
    Portfolio Receipts $2,975 million to $3,125 million
    (Growth of ~+6% to 12% year/year)    		 $2,900 million to $3,050 million
    (Growth of ~+4% to 9% year/year)
    Payments for operating and professional costs Approximately 10% of Portfolio Receipts Approximately 10% of Portfolio Receipts
    Interest paid $260 million $260 million

    The above Portfolio Receipts guidance represents expected growth of 6% to 12% in 2025. Royalty Pharma’s full year 2025 guidance reflects a negligible estimated foreign exchange impact to Portfolio Receipts, assuming current foreign exchange rates prevail for the rest of 2025.

    2025 guidance for payments for operating and professional costs and interest paid does not reflect the impact of the internalization transaction announced on January 10, 2025 and will be updated following the closing of the internalization transaction, which is expected in the second quarter of 2025.

    Total interest paid is based on the semi-annual interest payment schedule of Royalty Pharma’s existing notes and is anticipated to be approximately $260 million in 2025. Interest paid in the third quarter of 2025 is anticipated to be $119 million. De minimis amounts are anticipated in the second and fourth quarter of 2025. These projections assume no additional debt financing in 2025, including no drawdown on the revolving credit facility. In the first quarter of 2025, Royalty Pharma collected interest of $12 million on its cash and cash equivalents, which partially offset interest paid.

    Royalty Pharma today provides this guidance based on its most up-to-date view of its prospects. This guidance assumes no major unforeseen adverse events or changes in foreign exchange rates and excludes the contributions from transactions announced subsequent to the date of this press release.

    Financial Results Call

    Royalty Pharma will host a conference call and simultaneous webcast to discuss its first quarter 2025 results today at 8:30 a.m., Eastern Time. Please visit the “Investors” page of the company’s website at https://www.royaltypharma.com/investors/events to obtain conference call information and to view the live webcast. A replay of the conference call and webcast will be archived on the company’s website for at least 30 days.

    About Royalty Pharma plc

    Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry’s leading therapies. Royalty Pharma funds innovation in the biopharmaceutical industry both directly and indirectly – directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties, and indirectly when it acquires existing royalties from the original innovators. Royalty Pharma’s current portfolio includes royalties on more than 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 15 development-stage product candidates.

    Forward-Looking Statements

    The information set forth herein does not purport to be complete or to contain all of the information you may desire. Statements contained herein are made as of the date of this document unless stated otherwise, and neither the delivery of this document at any time, nor any sale of securities, shall under any circumstances create an implication that the information contained herein is correct as of any time after such date or that information will be updated or revised to reflect information that subsequently becomes available or changes occurring after the date hereof.

    This document contains statements that constitute “forward-looking statements” as that term is defined in the United States Private Securities Litigation Reform Act of 1995, including statements that express the company’s opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results, in contrast with statements that reflect historical facts. Examples include discussion of Royalty Pharma’s strategies, financing plans, growth opportunities, market growth and plans for capital deployment, plus the benefits of the internalization transaction, including expected accretion, enhanced alignment with shareholders, increased investment returns, expectations regarding management continuity, transparency and governance, and the benefits of simplification to its structure. In some cases, you can identify such forward-looking statements by terminology such as “anticipate,” “intend,” “believe,” “estimate,” “plan,” “seek,” “project,” “expect,” “may,” “will,” “would,” “could” or “should,” the negative of these terms or similar expressions. Forward-looking statements are based on management’s current beliefs and assumptions and on information currently available to the company. However, these forward-looking statements are not a guarantee of Royalty Pharma’s performance, and you should not place undue reliance on such statements. Forward-looking statements are subject to many risks, uncertainties and other variable circumstances, and other factors. Such risks and uncertainties may cause the statements to be inaccurate and readers are cautioned not to place undue reliance on such statements. Many of these risks are outside of the company’s control and could cause its actual results to differ materially from those it thought would occur. The forward-looking statements included in this document are made only as of the date hereof. The company does not undertake, and specifically declines, any obligation to update any such statements or to publicly announce the results of any revisions to any such statements to reflect future events or developments, except as required by law.
    Certain information contained in this document relates to or is based on studies, publications, surveys and other data obtained from third-party sources and the company’s own internal estimates and research. While the company believes these third-party sources to be reliable as of the date of this document, it has not independently verified, and makes no representation as to the adequacy, fairness, accuracy or completeness of, any information obtained from third-party sources. In addition, all of the market data included in this document involves a number of assumptions and limitations, and there can be no guarantee as to the accuracy or reliability of such assumptions. Finally, while the company believes its own internal research is reliable, such research has not been verified by any independent source.

    For further information, please reference Royalty Pharma’s reports and documents filed with the U.S. Securities and Exchange Commission (“SEC”) by visiting EDGAR on the SEC’s website at www.sec.gov.

    Portfolio Receipts

    Portfolio Receipts is a key performance metric that represents Royalty Pharma’s ability to generate cash from Royalty Pharma’s portfolio investments, the primary source of capital that is deployed to make new portfolio investments. Portfolio Receipts is defined as the sum of Royalty Receipts and Milestones and other contractual receipts. Royalty Receipts includes variable payments based on sales of products, net of contractual payments to the legacy non-controlling interests, that are attributed to Royalty Pharma.

    Milestones and other contractual receipts include sales-based or regulatory milestone payments and other fixed contractual receipts, net of contractual payments to legacy non-controlling interests, that are attributed to Royalty Pharma. Portfolio Receipts does not include royalty receipts and milestones and other contractual receipts that were received on an accelerated basis under the terms of the agreement governing the receipt or payment. Portfolio Receipts also does not include proceeds from equity securities or proceeds from purchases and sales of marketable securities, both of which are not central to Royalty Pharma’s fundamental business strategy.

    Portfolio Receipts is calculated as the sum of the following line items from Royalty Pharma’s GAAP condensed consolidated statements of cash flows: Cash collections from financial royalty assets, Cash collections from intangible royalty assets, Other royalty cash collections, Proceeds from available for sale debt securities and Distributions from equity method investees less Distributions to legacy non-controlling interests – Portfolio Receipts, which represent contractual distributions of Royalty Receipts, milestones and other contractual receipts to the Legacy Investors Partnerships.

    Use of Non-GAAP Measures

    Adjusted EBITDA and Portfolio Cash Flow are non-GAAP liquidity measures that exclude the impact of certain items and therefore have not been calculated in accordance with GAAP. Management believes that Adjusted EBITDA and Portfolio Cash Flow are important non-GAAP measures used to analyze liquidity because they are key components of certain material covenants contained within Royalty Pharma’s credit agreement. Royalty Pharma cautions readers that amounts presented in accordance with the definitions of Adjusted EBITDA and Portfolio Cash Flow may not be the same as similar measures used by other companies or analysts. These non-GAAP liquidity measures have limitations as analytical tools, and you should not consider them in isolation or as a substitute for the analysis of Royalty Pharma’s results as reported under GAAP.

    The definitions of Adjusted EBITDA and Portfolio Cash Flow used by Royalty Pharma are the same as the definitions in the credit agreement. Noncompliance with the interest coverage ratio, leverage ratio and Portfolio Cash Flow ratio covenants under the credit agreement could result in lenders requiring the company to immediately repay all amounts borrowed. If Royalty Pharma cannot satisfy these covenants, it would be prohibited under the credit agreement from engaging in certain activities, such as incurring additional indebtedness, paying dividends, making certain payments, and acquiring and disposing of assets. Consequently, Adjusted EBITDA and Portfolio Cash Flow are critical to the assessment of Royalty Pharma’s liquidity.

    Adjusted EBITDA and Portfolio Cash Flow are used by management as key liquidity measures in the evaluation of the company’s ability to generate cash from operations. Management uses Adjusted EBITDA and Portfolio Cash Flow when considering available cash, including for decision-making purposes related to funding of acquisitions, debt repayments, dividends and other discretionary investments. Further, these non-GAAP liquidity measures help management, the audit committee and investors evaluate the company’s ability to generate liquidity from operating activities.

    The company has provided reconciliations of these non-GAAP liquidity measures to the most directly comparable GAAP financial measure, being net cash provided by operating activities in Table 4.

    Royalty Pharma Investor Relations and Communications

    +1 (212) 883-6772
    ir@royaltypharma.com

     
    Royalty Pharma plc
    Condensed Consolidated Statements of Operations (unaudited)
    Table 1
     
      Three Months Ended March 31,
    ($ in millions) 2025   2024  
    Income and other revenues    
    Income from financial royalty assets 539   542  
    Other royalty income and revenues 29   26  
    Total income and other revenues 568   568  
    Operating (income)/expense    
    Provision for changes in expected cash flows from financial royalty assets (127)   584  
    Research and development funding expense 51   1  
    General and administrative expenses 111   58  
    Total operating expense, net 34   642  
    Operating income/(loss) 534   (74)  
    Other (income)/expense    
    Equity in (earnings)/losses of equity method investees (6)   14  
    Interest expense 65   44  
    Other expense/(income), net 42   (128)  
    Total other expense/(income), net 101   (70)  
    Consolidated net income/(loss) before tax 433   (4)  
    Income tax expense —   —  
    Consolidated net income/(loss) 433   (4)  
    Net income/(loss) attributable to non-controlling interests 195   (9)  
    Net income attributable to Royalty Pharma plc 238   5  

    Amounts may not add due to rounding.

     
    Royalty Pharma plc
    Selected Balance Sheet Data (unaudited)
    Table 2
     
    ($ in millions) As of March 31, 2025 As of December 31, 2024
    Cash and cash equivalents 1,088 929
    Total current and non-current financial royalty assets, net 15,749 15,911
    Total assets 17,608 18,223
    Current portion of long-term debt 999 998
    Long-term debt, net of current portion 6,619 6,615
    Total liabilities 7,820 7,880
    Total shareholders’ equity 9,789 10,342

     

     
    Royalty Pharma plc
    Condensed Consolidated Statements of Cash Flows (unaudited)
    Table 3
     
       
      Three Months Ended March 31,
    ($ in millions) 2025   2024  
    Cash flows from operating activities:    
    Cash collections from financial royalty assets 830   745  
    Cash collections from intangible royalty assets 0   14  
    Other royalty cash collections 32   26  
    Distributions from equity method investees 13   13  
    Interest received 12   6  
    Development-stage funding payments (51)   (1)  
    Payments for operating and professional costs (102)   (61)  
    Interest paid (139)   (79)  
    Net cash provided by operating activities 596   665  
    Cash flows from investing activities:    
    Distributions from equity method investees 36   5  
    Investments in equity method investees —   (7)  
    Purchases of equity securities (4)   —  
    Proceeds from available for sale debt securities 13   1  
    Proceeds from sales of available for sale debt securities 511   —  
    Acquisitions of financial royalty assets (1)   (86)  
    Milestone payments (50)   —  
    Net cash provided by/(used in) investing activities 504   (87)  
    Cash flows from financing activities:    
    Distributions to legacy non-controlling interests – Portfolio Receipts (85)   (88)  
    Distributions to continuing non-controlling interests (54)   (32)  
    Dividends to shareholders (95)   (94)  
    Repurchases of Class A ordinary shares (709)   —  
    Contributions from legacy non-controlling interests – R&D 0   0  
    Contributions from non-controlling interests – other 1   1  
    Net cash used in financing activities (941)   (212)  
    Net change in cash and cash equivalents 159   366  
    Cash and cash equivalents, beginning of period 929   477  
    Cash and cash equivalents, end of period 1,088   843  

    Amounts may not add due to rounding.

     
    Royalty Pharma plc
    GAAP to Non-GAAP Reconciliation (unaudited)
    Table 4
     
      Three Months Ended March 31,
    ($ in millions) 2025   2024  
    Net cash provided by operating activities (GAAP) 596   665  
    Adjustments:    
    Proceeds from available for sale debt securities(6) 13   1  
    Distributions from equity method investees(6) 36   5  
    Interest paid, net(6) 127   73  
    Development-stage funding payments 51   1  
    Distributions to legacy non-controlling interests – Portfolio Receipts(6) (85)   (88)  
    Adjusted EBITDA (non-GAAP) 738   656  
    Interest paid, net(6) (127)   (73)  
    Portfolio Cash Flow (non-GAAP) 611   584  

    Amounts may not add due to rounding.

     
    Royalty Pharma plc
    Description of Approved Indications for Select Portfolio Therapies
    Table 5
     
    Cystic fibrosis franchise Cystic fibrosis
    Trelegy Chronic obstructive pulmonary disease and asthma
    Tysabri Relapsing forms of multiple sclerosis
    Evrysdi Spinal muscular atrophy
    Xtandi Prostate cancer
    Imbruvica Hematological malignancies and chronic graft versus host disease
    Promacta Chronic immune thrombocytopenia purpura and aplastic anemia
    Tremfya Plaque psoriasis, psoriatic arthritis, ulcerative colitis and Crohn’s disease
    Cabometyx/Cometriq Kidney, liver and thyroid cancer
    Spinraza Spinal muscular atrophy
    Trodelvy Breast and bladder cancer
    Erleada Prostate cancer


    Notes

    (1)   Portfolio Receipts is a key performance metric that represents our ability to generate cash from Royalty Pharma’s portfolio investments, the primary source of capital that Royalty Pharma can deploy to make new portfolio investments. Portfolio Receipts is defined as the sum of Royalty Receipts and Milestones and other contractual receipts. Royalty Receipts includes variable payments based on sales of products, net of contractual payments to the legacy non-controlling interests, that are attributed to Royalty Pharma (“Royalty Receipts”). Milestones and other contractual receipts include sales-based or regulatory milestone payments and other fixed contractual receipts, net of contractual payments to the legacy non-controlling interests, that are attributed to Royalty Pharma. Portfolio Receipts does not include royalty receipts and milestones and other contractual receipts that were received on an accelerated basis under the terms of the agreement governing the receipt or payment. Portfolio Receipts also does not include proceeds from equity securities or marketable securities, both of which are not central to Royalty Pharma’s fundamental business strategy.

    Portfolio Receipts is calculated as the sum of the following line items from Royalty Pharma’s GAAP condensed consolidated statements of cash flows: Cash collections from financial royalty assets, Cash collections from intangible royalty assets, Other royalty cash collections, Proceeds from available for sale debt securities and Distributions from equity method investees less Distributions to legacy non-controlling interests – Portfolio Receipts, which represent contractual distributions of Royalty Receipts, milestones and other contractual receipts to the Legacy Investors Partnerships.

    (2)   Adjusted EBITDA is defined under the credit agreement as Portfolio Receipts minus payments for operating and professional costs. Operating and professional costs reflect Payments for operating and professional costs from the GAAP statements of cash flows. See GAAP to Non-GAAP reconciliation in Table 4.

    (3)   Portfolio Cash Flow is defined under the credit agreement as Adjusted EBITDA minus interest paid or received, net. See GAAP to Non-GAAP reconciliation in Table 4. Portfolio Cash Flow reflects the cash generated by Royalty Pharma’s business that can be redeployed into value-enhancing royalty acquisitions, used to repay debt, returned to shareholders through dividends or share purchases or utilized for other discretionary investments.

    (4)   Capital Deployment is calculated as the summation of the following line items from Royalty Pharma’s GAAP condensed consolidated statements of cash flows: Investments in equity method investees, Purchases of available for sale debt securities, Acquisitions of financial royalty assets, Acquisitions of other financial assets, Milestone payments, Development-stage funding payments less Contributions from legacy non-controlling interests – R&D.

    (5)   Other products primarily include Royalty Receipts on the following products: Cimzia, Crysvita, Emgality, Entyvio, Farxiga/Onglyza, IDHIFA, Nesina, Nurtec ODT, Orladeyo, Rytelo, Soliqua, Voranigo and distributions from the Legacy SLP Interest, which is presented as Distributions from equity method investees on the GAAP condensed consolidated statements of cash flows.

    (6)   The table below shows the line item for each adjustment and the direct location for such line item on the GAAP condensed consolidated statements of cash flows.

    Reconciling Adjustment Statements of Cash Flows Classification
    Interest paid, net Operating activities (Interest paid less Interest received)
    Distributions from equity method investees Investing activities
    Proceeds from available for sale debt securities Investing activities
    Distributions to legacy non-controlling interests – Portfolio Receipts Financing activities
       

    (7)   The total transaction value of approximately $1.1 billion is based on the closing price of Royalty Pharma plc common stock of $26.20 on January 8, 2025.

    (8)   Consists of $200 million in cash less the amount of the management fees paid to the Manager from January 1, 2025 through the closing of the transaction.

    The MIL Network –

  • MIL-OSI: Biz2Credit’s Annual Top 25 Cities for Small Business Report Identifies Worcester, MA as #1

    Source: GlobeNewswire (MIL-OSI)

    NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) — The 2025 Biz2Credit Top Cities for Small Business Study has identified Worcester, MA, as the top city for small businesses in its annual financial analysis. According to Biz2Credit’s analysis, the other cities in the top five are: Ventura, CA, Stamford, CT, Portland, OR, and San Jose, CA.  

    The study examined financial indicators, including annual revenue, credit score, age of business, and the proprietary BizAnalyzer® scores of businesses that applied for funding with Biz2Credit during 2024. The analysis found that small businesses’ average revenue increased while credit scores dipped slightly. 

    Key Findings:  

    • The top 25 study saw moderate changes compared to 2024, with the most notable being California’s tech-heavy bay area losing its top two spots. 
    • The leading industries among the top cities are retail trade, construction, healthcare & social assistance, and accommodation and food services. 
    • Average credit scores decreased by 5 points, from 652 to 647.  
    • Seven cities are new to the list this year: Worcester, MA (1), Buffalo, NY (11), Fresno, CA (15), Richmond, VA (17), Myrtle Beach, SC (23), New Haven, CT (24), Indianapolis, IN (25) 
    • Eight cities fell off the 2024 list: Pittsburgh, PA, Sacramento, CA, Minneapolis, MN, Port St. Lucie, FL, Philadelphia, PA, Hartford, CT, Riverside, CA, and Phoenix, AZ all fell outside the top 25 from last year’s list. This is the same number that fell off in Biz2Credit’s 2024 study. 

    The Top 25 Cities for Small Business for this year (with 2024 ranking in parenthesis) are:  

    1. Worcester, MA (unranked)
    2. Ventura/Oxnard, CA (13) 
    3. Greater Bridgeport, CT (5) 
    4. Portland, OR (7) 
    5. San Jose, CA (1) 
    6. Seattle, WA (4) 
    7. Salt Lake City, UT (11) 
    8. Colorado Springs, CO (3) 
    9. Nashville, TN (22) 
    10. Denver, CO (15) 
    11. Buffalo, NY (unranked) 
    12. Providence, RI (9) 
    13. San Diego, CA (6) 
    14. San Francisco, CA (2) 
    15. Fresno, CA (unranked) 
    16. Boston, MA (12) 
    17. Richmond, VA (unranked) 
    18. New York City, NY (8) 
    19. Los Angeles, CA (17) 
    20. Washington, D.C. (16) 
    21. Baltimore, MD (10) 
    22. Hartford, CT (23) 
    23. Myrtle Beach, SC (unranked) 
    24. New Haven, CT (unranked) 
    25. Indianapolis, IN (unranked) 

    “Small businesses in Ventura County (Ventura and Oxnard) had high average annual revenues ($1,075,489), strong average credit score (679), and are mature businesses,” said Rohit Arora, CEO of Biz2Credit and one of the nation’s leading experts in small business finance. “This year’s top 5 continues to show the strength of our nation’s coastal states as hubs for small and medium size businesses.” 

    Methodology  

    The data included in this study was collected from submitted cases between Jan. 1, 2024, and Dec. 31, 2024. The study encompassed more than 75,000 applications. Biz2Credit set a threshold of 150 applications for an MSA (Metropolitan Statistical Area) to be included in the 2024 study. As a result, the MSA level analysis was based on 49,940 cases above the threshold. Data pertaining to state name, MSA, and ZIP code is from the U.S. Census.  

    The 2025 Top 25 Cities Study is based on actual verified cash flows of merchants on the Biz2Credit platform during 2024. Submitted cases with an annual revenue exceeding $5 million were excluded from the revenue analysis. The ranking of cities in the study was established using BizAnalyzer Score (BA Score), a proprietary score developed by Biz2Credit. To determine the BA Score, Biz2Credit examined several key factors, including Credit Score, Annual Revenue, Age of Business, Debt-to-Income Ratio, and Cash Flow Analytics powered by Bank Statement Analyzer. 

    About Biz2Credit  

    Founded in 2007, Biz2Credit has helped thousands of companies access more than in small business financing. Biz2Credit is headquartered in New York City, employs over 800 people with over half in product, data science, and engineering roles. Using data analytics and predictive modeling, Biz2Credit seeks to enhance the accuracy and transparency of business credit decisions, fueling long-term economic development. Visit www.biz2credit.com, or follow the company on LinkedIn, Instagram, Facebook, and X (formerly Twitter).

    Media Contact: Brett Holzhauer, (818) 326-1109, brett.holzhauer@biz2credit.com 

    The MIL Network –

  • MIL-OSI Europe: VATICAN – Mass “pro eligendo Romano Pontifice”: “Not a simple succession of persons, yet it is always the Apostle Peter who returns”

    Source: Agenzia Fides – MIL OSI

    Wednesday, 7 May 2025

    Fabio Beretta/Agenzia Fides

    Vatican City (Agenzia Fides) – “The election of the new Pope is not a simple succession of persons, yet it is always the Apostle Peter who returns.” A few hours before the start of the Conclave, the College of Cardinals traditionally met in St. Peter’s Basilica for the Mass “pro eligendo Romano Pontifice.”A total of 220 cardinals were present, including electors and non-electors; 5,000 faithful participated in the Mass in St. Peter’s Basilica. Cardinal Giovanni Battista Re, Dean of the Sacred College, presided over the Eucharistic concelebration. “We are here to invoke the help of the Holy Spirit, to implore his light and strength so that the Pope elected may be he whom the Church and humanity need at this difficult and complex turning point in history,” he said in his homily, adding: “We feel united with the entire People of God in their sense of faith, love for the Pope and confident expectation.””To pray, by invoking the Holy Spirit Prayer,” Cardinal Re emphasized, “is the only right and proper attitude to take as the Cardinal electors prepare to undertake an act of the highest human and ecclesial responsibility and to make a choice of exceptional importance. This is a human act for which every personal consideration must be set aside, keeping in mind and heart only the God of Jesus Christ and the good of the Church and of humanity.”In his commentary on the liturgical texts of the Eucharistic celebration, the Dean of the College of Cardinals recalled “among the tasks of every successor of Peter is that of fostering communion: communion of all Christians with Christ; communion of the Bishops with the Pope; communion of the Bishops among themselves. This is not a self-referential communion, but one that is entirely directed towards communion among persons, peoples and cultures, with a concern that the Church should always be a “home and school of communion.””Hence the “strong call to maintain the unity of the Church on the path traced out by Christ to the Apostles,” because “each Pope continues to embody Peter and his mission and thus represents Christ on earth; he is the rock on which the Church is built.” And therefore, “the election of the new Pope is not a simple succession of persons, yet it is always the Apostle Peter who returns.”Cardinal Re then cited John Paul II’s Roman Triptych, a book of poems and meditations in which the Polish Pope expressed his hope “that during the hours of voting on this weighty decision, Michelangelo’s looming image of Jesus the Judge would remind everyone of the greatness of the responsibility of placing the “supreme keys” (Dante) in the correct hands.””Let us pray, then, that the Holy Spirit, who in the last hundred years has given us a series of truly holy and great Pontiffs, will give us a new Pope according to God’s heart for the good of the Church and of humanity. Let us pray that God will grant the Church a Pope who knows how best to awaken the consciences of all and the moral and spiritual energies in today’s society, characterised by great technological progress but which tends to forget God.Today’s world expects much from the Church regarding the safeguarding of those fundamental human and spiritual values without which human coexistence will not be better nor bring good to future generations,” Re concluded.In the afternoon, at 4:30 p.m., the 133 Cardinals electors entered the Sistine Chapel, opening the Conclave that will elect the 266th successor of Peter. (F.B.) (Agenzia Fides, 7/5/2025)
    Fabio Beretta/Agenzia Fides

    Fabio Beretta/Agenzia Fides

    Fabio Beretta/Agenzia Fides

    Fabio Beretta/Agenzia Fides

    Fabio Beretta/Agenzia Fides

    Fabio Beretta/Agenzia Fides

    Share:

    MIL OSI Europe News –

  • MIL-OSI United Kingdom: Advanced tech boosts fight against animal and plant disease

    Source: United Kingdom – Government Statements

    Press release

    Advanced tech boosts fight against animal and plant disease

    £10 million in new Government funding for surveillance programme will further strengthen the country’s biosecurity to protect animals, plants, people and trade.

    The fight against pests and diseases, which can cost the UK economy billions of pounds, has been stepped up today (Thursday 8 May) with £10m of new funding announced for surveillance projects.

    The Genomics for Animal and Plant Disease Consortium (GAP-DC) project led by the Animal and Plant Health Agency will undertake surveillance across animal, plant and aquatic environments, using advanced genome sequencing technologies – a method that reads the complete genetic code of a living organism, including viruses, bacteria, fungi, or animals – to detect, identify and track pathogens with precision.

    For example, when avian influenza is found in UK poultry, genome sequencing can help confirm the virus type, trace its spread, and detect any mutations, supporting disease control measures.

    The UK faces significant and growing economic threats from pests and diseases affecting agriculture, livestock, and the environment. Invasive species alone cost the UK economy an estimated £4 billion annually, while plant pathogens and pests contribute to substantial crop losses.

    Ash dieback is predicated to cost £15 billion to the UK over coming decades and livestock disease such as avian influenza can have devastating financial and societal consequences, and has been estimated to cost the poultry meat sector more than £100m over a two-year period.

    APHA Interim Chief Executive Dr Jenny Stewart said:

    “Disease presents a significant risk to our farmers, global trade and human health.

    “This vital funding and collaboration with world leading experts will help APHA identify and tackle disease risk more effectively.

    “This research will lead to significantly advanced surveillance capabilities to protect UK borders from new and existing threats.”

    Research to be undertaken in collaboration with seven expert partners will include a focus on increasing the speed of pathogen detection at our borders, addressing new and re-emerging disease outbreaks, developing new strategies to control and mitigate endemic disease, and an improved approach to working with stakeholders and the community. It will also investigate disease spillover from wild animals and plants – when a virus moves from one species to other, such as the transmission of the COVID-19 virus from bats to humans.

    The £10 million of new funding provided by Defra and UK Research and Innovation (UKRI) will strengthen pathogen detection across the UK over the next two years and help protect the UK economy, as part of the Government’s Plan for Change.

    The announcement comes during National Plant Health Week (5-12 May 2025), an annual designated week of action to raise public awareness and engagement on how to keep our plants healthy, led by Defra in partnership with 32 organisations, including the Royal Horticultural Society, the Woodland Trust and the Horticultural Trades Association.

    Additional information:

    • APHA is an executive agency, sponsored by the Department for Environment, Food & Rural Affairs, the Welsh Government, and the Scottish Government, which employs around 3,600 staff, based at various sites across the UK.
    • The GAP-DC project will help APHA to get a better understanding of new sequencing technologies and platforms available in genomic surveillance so that we can test more effectively.
    • The project is supported by £7 million of funding from Defra and £3m from UKRI.
    • A full list of partners involved in the project is below:

    -Animal and Plant Health Agency (lead)

    • Defra

    • UKRI

    • Forest Research

    • Centre for Environment, Fisheries and Aquaculture Science (Cefas)

    • The Pirbright Institute

    • Fera Science

    • Royal Veterinary College

    • Forest Research Head of Pathology Dr Lisa Ward said:

    “Forest Research is internationally renowned for the provision of science, research, evidence, data and services for the support of sustainable forestry.

    “The genomic methods being developed under the GAP DC project are essential to future proof Forest Research’s work on monitoring the health of our trees by enhancing early pathogen detection, allowing rapid response and more effective disease control.”

    • Royal Veterinary College Vice Principal for Research and Innovation Professor Oliver Pybus said:

    “The Royal Veterinary College is pleased to contribute its expertise in infectious disease genomics and animal health to GAP-DC.

    “The consortium will further strengthen the UK’s position as a world-leader in genomic surveillance for animal and plant pathogens”

    • Cefas Animal and Human Health Science Lead Professor David Bass said:

    “Cefas, an Executive Agency of Defra, has diverse expertise in marine and freshwater science, working for healthy and productive oceans, seas, and rivers, and safe and sustainable seafood.

    “Genomic methods for pathogen surveillance and understanding the health of aquatic organisms are central to this mission, so we greatly value our participation in GAP-DC, and contributing to the UK’s excellence and innovation in pathogen genomics.”

    Updates to this page

    Published 8 May 2025

    MIL OSI United Kingdom –

  • MIL-OSI: Axiomise Featured Gold Sponsor at RISC-V Summit Europe Next Week in Paris

    Source: GlobeNewswire (MIL-OSI)

    • Ongoing Booth Demos of Axiomise’s formalISA bug hunter and footprint for end-to-end architectural verification
    • Lightning Talk, Presentation on Benefits of Formal Verification for RISC-V Verification from Founder and CEO Dr. Ashish Darbari

    LONDON, May 08, 2025 (GLOBE NEWSWIRE) — Axiomise®, the leading provider of cutting-edge formal verification solutions, will feature the effectiveness of its formal verification solutions for corner-case bug hunting at the RISC-V Summit Europe next week in Paris.

    RISC-V Summit Europe attendees will see demonstrations of Axiomise’s formalISA® that find previously missed bugs and footprint®, part of the axiomiser® platform for end-to-end architectural verification. Visit Axiomise in Booth #04 Tuesday, May 13, through Thursday, May 15, at La Cité des Sciences et de l’Industrie.

    Dr. Ashish Darbari, a formal verification expert and Axiomise’s Founder and CEO, will give a two-minute lightning talk Tuesday in the plenary conference room titled “Getting Towards First-Time RISC-V Silicon with Automated End-to-End Formal.” Dr. Darbari will address how smart formal methods powered by its formalISA and footprint can empower designers to build RISC-V silicon right the first time. The talk will highlight how the Axiomise tools go beyond compliance testing by “axiomising” correctness through exhaustive proofs, exposing corner-case bugs and coverage for functional power, performance and area (PPA), safety and security verification.

    Wednesday morning’s program includes” Making RISC-V Market-Ready: The Economic Case for Formal Verification,” a presentation by Dr. Darbari. He will share how automated formal methods can shrink time to market and costs to get RISC-V processors and SoCs ready. The talk will go beyond compliance verification, highlighting advanced techniques such as formal method-based bug hunting, exhaustive proofs and comprehensive coverage to achieve high certification quality.

    The Axiomise Edge
    Axiomise builds solutions to tackle corner-case bug hunting for RISC-V processors through formal proofs to identify bugs in security processors such as cheriot-ibex and superscalar processors like CVA6.
    Its formalISA app has been deployed in the verification of dozens of processors, finding bugs previously missed by other verification tools and providers. Using Axiomise’s formalISA, exhaustive architectural compliance through full proofs and end-to-end architectural verification is possible. The footprint app has been deployed in the testing of more than 85 different designs.

    To arrange a demonstration or private meeting, send email to info@axiomise.com.

    About Axiomise
    Axiomise is accelerating formal verification adoption through its unique combination of training, consulting, services and specialized verification solutions for RISC-V. Axiomise was founded by Dr. Ashish Darbari, FBCS, FIETE, DPhil (Oxford), who has been a formal verification practitioner for more than two decades with 67 patents in formal verification and over 85 publications.

    Engage with Axiomise at:
    Website: www.axiomise.com
    X: @axiomise
    LinkedIn: https://www.linkedin.com/company/axiomise/

    Axiomise, formalISA, footprint, axiomiser and the Axiomise logo are trademarks of Axiomise Limited, UK.

    Making formal normal is a registered trademark of Axiomise Limited, UK.

    For more information, contact:
    Fabiana Muto
    Public Relations for Axiomise
    fabiana.muto@axiomise.com

    The MIL Network –

  • MIL-OSI United Kingdom: Appointment of Law Commissioners to the Law Commission

    Source: United Kingdom – Executive Government & Departments

    News story

    Appointment of Law Commissioners to the Law Commission

    The Lord Chancellor has approved the appointment of Professor Solene Rowan and Professor Lisa Webley as Commissioners of the Law Commission of England and Wales.

    The Lord Chancellor has approved the appointment of:

    • Professor Solene Rowan as the Law Commissioner for Commercial & Common Law from 8 September 2025 to 7 September 2030
    • Professor Lisa Webley as the Law Commissioner for Property, Family & Trust Law from 1 September 2025 to 31 August 2030.

    Professor Solène Rowan

    Professor Solène Rowan is currently the Chair of Contract Law, the Vice-Dean for Students, Culture & Community, and the Director of the LLB / Master 1 programme at the Dickson Poon School of Law, King’s College London. She is also an Honorary Professor at the Australian National University and a Visiting Professor at Paris Panthéon-Assas University. 

    Solène’s principal areas of expertise are contract law, commercial law, and comparative law, all with a particular focus on remedies. She is an award-winning author of two monographs and articles in leading international legal publications, and a member of the editorial team of Chitty on Contracts. Her work has been widely cited by law reformers and courts domestically and abroad.

    Solène was previously a Professor at the University of Oxford, an Associate Professor at the London School of Economics and Political Science and the Australian National University, and a Fellow and College Lecturer in Law at Queens’ College, Cambridge. She read law as an undergraduate at King’s College London and Paris Panthéon-Sorbonne University and obtained an LLM and a PhD from the University of Cambridge.

    Professor Lisa Webley

    Since 2018, Professor Webley has been the Chair in Legal Education and Research for the Birmingham Law School, University of Birmingham. From 2019 –2023, she served as Head and Dean of Birmingham Law School.

    Both did not declare any political activity.

    The Law Commission aims to ensure that the law is as fair, modern, simple and as cost-effective as possible. It conducts research and consultations to make systematic recommendations for consideration by Parliament.

    Appointments of Commissioners to the Law Commission are made by the Lord Chancellor under the Law Commissions Act 1965.  Appointments are regulated by the Commissioner for Public Appointments and recruitment processes comply with the Governance Code on Public Appointments.

    Updates to this page

    Published 8 May 2025

    MIL OSI United Kingdom –

  • MIL-OSI: Columbus Interim Report Q1 2025

    Source: GlobeNewswire (MIL-OSI)

    Company announcement no. 5/2025

    Solid operational performance in Q1 2025

    Columbus delivered a solid start to 2025, driven by improved earnings, confirming the robustness of the strategy and business model. Despite a slight decline in revenue of 2%, a 32% improvement in EBITDA was achieved, significantly strengthening profitability and increasing the EBITDA margin to 10.7% compared to 7.9% in Q1 2024, adjusted for the extraordinary gain of DKK 20m from the M3CS legal case. Overall, a satisfactory start to the year.

    “Despite global uncertainty, Q1 2025 reflects steady execution – confirming that our strategy supports both resilience and improved profitability.” CEO & President Søren Krogh Knudsen.

    Q1 2025 highlights

    • Revenue declined by 2%, amounting to DKK 434m.
    • EBITDA amounted to DKK 46m, up 32% compared with the adjusted EBITDA in Q1 2024.
    • EBITDA margin was 10.7%, compared to 7.9% in Q1 2024 when adjusted for the M3CS legal case.
    • Efficiency of 62% in Q1 2025, compared to 62% in Q1 2024.
    • Consistent solid cash flow achieved with DKK 17m from operating activities.

    Service revenue split on Business Lines

           
    DKK ´000 Q1 2025 Q1 2024 ∆%
           
    Dynamics 365 253,059 257,433 -2%
    M3 84,814 93,074 -9%
    Digital Commerce 47,242 53,379 -11%
    Data & AI 23,950 18,707 28%
    Other Local Business 4,958 6,249 -21%
    Total sale of services 414,023 428,842 -3%
           
    Total sale of products 19,932 15,398 29%
           
    Total net revenue 433,955 444,240 -2%

    Service revenue split on Market Units

           
    DKK ´000 Q1 2025 Q1 2024 ∆%
           
    Sweden 130,943 147,946 -11%
    Denmark 102,318 108,318 -6%
    Norway 54,217 66,115 -18%
    UK 88,369 75,534 17%
    US 29,336 19,555 50%
    Other 8,575 10,104 -15%
    GDC 265 1,270 -79%
    Total sale of services 414,023 428,842 -3%
           
    Total sale of products 19,932 15,398 29%
           
    Total net revenue 433,955 444,240 -2%

    Outlook for 2025
    Based on the financial performance in Q1 2025 and the current order book and pipeline forecast, we maintain our full year guidance for 2025, as announced in Company release no. 1/2025 of 17 January 2025:

    • Organic revenue growth of 7-9%
    • EBITDA margin of 10-12%

    Live webcast and conference call
    Columbus is hosting a live webcast and conference call on 8 May 2025 at 13:00 CET. The webcast is hosted by CEO & President Søren Krogh Knudsen and CFO Brian Iversen.

    Webcast: Please log in to the webcast via Columbus’ investor site where you can follow the presentation and submit your written questions during the call: https://ir.columbusglobal.com/calendar-and-events

    Conference call:

    1. Participants are required to register in advance of the conference using the link provided below. Upon registering, each participant will be provided with Participant Dial In Numbers, and a unique Personal PIN.

    2. In the 10 minutes prior to call start time, Participants will need to use the conference access information provided in the e-mail received at the point of registering. Participants may also use the call me feature instead of dialling the nearest dial in number.

    Online Registration to the call: https://register.vevent.com/register/BI4a2761164a604663a705eed93a1f9f7c

    Live presentation on 12 May 2025
    HC Andersen Capital will host a live presentation of Q1 2025 results on 12 May 2025 at 11:00 CET. Presenters from Columbus A/S will be CEO & President Søren Krogh Knudsen and CFO Brian Iversen.

    You can already now submit questions and sign up for the event via this link: https://www.inderes.dk/videos/columbus-q1-2025-report-presentation

    A recording of the presentation will be available via the same link.

    For further information, please contact:

    • Søren Krogh Knudsen, CEO & President, Tel.: +45 7020 5000

    About Columbus 
    Columbus is a consultancy company helping organisations drive business value by defining, executing, and evolving their entire business. We deliver digital value through human intelligence, enabling our customers to innovate and grow. Our more than 1,500 digital explorers guide our customers through their digital transformation, delivering lasting value in Manufacturing, Retail & Distribution, Food & Beverage, and Life Science.

    We advise, implement and manage business critical solutions within Cloud Services, Data & AI, Sales, Marketing, Customer & Field Service, Digital Commerce, Managed Services, Business Process Automation & Apps, Finance & Supply Chain, Enterprise Information Management, Cybersecurity and Transformation Strategy. Headquartered in Denmark, we have offices and partners worldwide – delivering locally on a global scale.

    Attachment

    The MIL Network –

  • MIL-OSI Russia: The 28th Eurasian Economic Summit is dedicated to finding solutions to global problems

    Translation. Region: Russian Federal

    Source: People’s Republic of China in Russian – People’s Republic of China in Russian –

    Source: People’s Republic of China – State Council News

    ISTANBUL, May 8 (Xinhua) — The 28th Eurasian Economic Summit kicked off in Istanbul on Wednesday to discuss ways to address pressing global issues such as conflicts, climate change, economic inequality and migration.

    The two-day summit, themed “A More Humane World – Dialogue for a Livable World,” is organized by Istanbul-based Marmara Group Foundation for Strategic and Social Research.

    Foundation President Akkan Suver described the summit as a unique platform for promoting inclusive dialogue between representatives of different countries around the world.

    “In a world increasingly characterized by conflict and polarization, our theme, ‘Dialogue for a World Fit to Live in’, highlights the urgent need for civil society, reason and conscience to guide us towards peace and cooperation,” he said in his opening remarks.

    The summit includes a number of sessions, including “Ecology, Economy, Energy and Artificial Intelligence” and “International Health Cooperation”, which highlight the multifaceted approach needed to address global challenges.

    One of the main events of the summit will be a session on “Disaster-Resilient Cities”, where world leaders will consider ways to strengthen urban infrastructure and ensure resilience to the growing threat of natural disasters caused by climate change.

    In addition, the Peace and Dialogue session will explore new approaches to peacebuilding and create opportunities for constructive dialogue in an increasingly polarized world.

    The summit is attended by more than 300 politicians, diplomats, scientists and entrepreneurs from almost 50 countries. –0–

    MIL OSI Russia News –

  • MIL-OSI China: Xi urges safeguarding legacy of WWII victory

    Source: People’s Republic of China – State Council News

    MOSCOW, May 8 — Chinese President Xi Jinping on Wednesday called for concerted efforts to defend the legacy of World War II (WWII) victory as the world is once again reeling from the specter of hegemonism and power politics.

    Xi made the call as he arrived in Moscow for a state visit to Russia and celebrations marking the 80th anniversary of the victory in the Soviet Union’s Great Patriotic War.

    In a written statement issued upon arrival, Xi said China and Russia will work together to safeguard the victorious outcome of WWII, and resolutely oppose hegemonism and power politics.

    China and Russia, both major countries of the world and permanent members of the UN Security Council, will join hands to firmly safeguard the UN-centered international system and the international order underpinned by international law, practice true multilateralism, and promote the building of a more just and equitable global governance system, he said.

    Xi’s visit comes at the invitation of Russian President Vladimir Putin. This marks his 11th visit to Russia since he became the president of China.

    During his stay, Xi is expected to have in-depth communication with Putin on bilateral relations and cooperation, as well as major international and regional issues of common concern.

    According to China’s Foreign Ministry, Xi’s attendance at the celebrations marking the 80th anniversary of the victory in the Soviet Union’s Great Patriotic War is an important part of his visit. It will be Xi’s second time attending Russia’s May 9 Victory Day commemorations as Chinese president.

    A massive military parade will take place in Moscow’s Red Square on Friday. Flags with the word “Victory” fluttered in the wind along the streets of Moscow, and the roads were lined with billboards and decorative windows depicting the history of the Great Patriotic War of the Soviet Union.

    On the night of May 8, 1945, Germany signed the surrender document in Karlshorst, Berlin, marking the end of WWII in Europe. However, due to the time difference, Moscow had already entered May 9 — the date the Soviet Union, and later Russia, commemorates as “Victory Day.”

    Meanwhile in Asia, China’s final major campaign against Japan — the Battle of Western Hunan — reached its decisive phase. Japan’s surrender aboard the USS Missouri in Tokyo Bay on Sept. 2, 1945, brought WWII to an end.

    In a signed article published in the Russian Gazette newspaper ahead of his arrival, Xi urged the international community to uphold a correct historical perspective on WWII.

    “China and the Soviet Union were the principal theaters of that war in Asia and Europe respectively,” Xi wrote. “The two countries served as the mainstay of resistance against Japanese militarism and German Nazism, making pivotal contribution to the victory of the World Anti-Fascist War.”

    “Any attempt to distort the historical truth of WWII, deny its victorious outcome, or defame the historic contribution of China and the Soviet Union is doomed to fail,” Xi wrote.

    The year of 2025 also marks the 80th anniversary of the founding of the United Nations. The world body arose from the ashes of WWII. The UN Charter begins with a solemn pledge: “to save succeeding generations from the scourge of war.”

    As the world is facing stiff headwinds from unilateralism, hegemonism, bullying and coercive practices, Xi emphasized the importance of multilateralism.

    “The more turbulent and complex the international situation becomes, the more we must uphold and defend the authority of the UN,” Xi wrote in his signed article.

    “The establishment of an international system with the United Nations at its core is not easy at all, and must be firmly maintained by all countries of the world,” said Ekaterina Zaklyazminskaya, leading researcher at the Institute of China and Modern Asia at the Russian Academy of Sciences.

    “Russia and China support genuine multilateralism, which is very important at this time,” said the researcher.

    The world is shifting irreversibly toward a multipolar order, with Russia and China playing essential roles in this transformation, said Alexey Rodionov, a professor of Chinese studies at St. Petersburg State University.

    China maintains a balanced stance on international issues, and that is why more countries now regard it as a key reference point in diplomacy and global policy, Rodionov said.

    MIL OSI China News –

  • MIL-OSI NGOs: Greenpeace vows to keep pressing antagonistic, evasive Woodside to protect climate and nature

    Source: Greenpeace Statement –

    PERTH Thursday, 8 May 2025 — Following Woodside’s 2025 AGM, David Ritter, CEO at Greenpeace Australia, said: 

    “Woodside Chairman Richard Goyder treated Greenpeace representatives at the AGM with unnecessary antagonism and evasiveness, but we will not relent on rigorous democratic scrutiny to hold Woodside accountable for its plans to wreck WA’s pristine oceans, Scott Reef, and our climate. 

    “From the proceedings at recent Woodside AGMs, it is abundantly clear that many Western Australians and Woodside shareholders are deeply concerned about the devastating potential impact of Woodside’s plans on our oceans, climate, health, and cultural heritage—and that Woodside is feeling the heat. 

    “Instead of responding to valid concern and scrutiny with antagonism, Woodside should focus on ensuring its plans align with what the science demands on nature protection and emissions reduction. We know that we must stop the extraction and burning of new fossil fuels, and transition to renewable energy at emergency speed and scale if we are to secure a safer climate in the future. 

    “Woodside’s proposed extension of the North West Shelf facility, and its plans to drill for gas near Scott Reef, pose an unacceptable risk to our oceans, and our climate. 

    “The hundreds of thousands of Australians who are deeply concerned about the future of our oceans, environment and climate, will continue to speak up against Woodside’s risky plans. Greenpeace calls on the Albanese government, which has just been elected with a strong climate mandate, to heed the evidence and reject Woodside’s planned North West Shelf extension and Browse gas field. 

    For more information or to arrange an interview, please contact Vai Shah on 0452 290 082 or [email protected].

    Photos from the protest and file photos for editorial use will be available here after the protest: Google Drive folder.

    MIL OSI NGO –

  • MIL-OSI Russia: Happy birthday to academician Georgy Kleiner!

    Translation. Region: Russian Federal

    Source: State University of Management – Official website of the State –

    On May 8, the day before the 80th anniversary of the Great Victory, the State University of Management congratulates one of the leading economists of the university and all of Russia, head of the Department of Institutional Economics at the IEF SUMU, Corresponding Member of the Russian Academy of Sciences, Doctor of Economics, Professor Georgy Kleiner on his birthday.

    Of course, these are not all of his positions and titles. For now, it will be enough to say that Georgy Borisovich at one time developed the concept of multi-level strategic planning, created a school of modern system analysis of the real sector of the Russian economy, and laid the foundations of the theory of systemic economics. Over the past 15 years, Professor Kleiner has been one of the first in the citation rating of Russian economists according to the Russian Science Citation Index. And there is something to cite, because he has written about 850 different scientific papers. For more than a quarter of a century, the hero of today’s celebration has been working at the State University of Management and still speaks at conferences and his open lectures, sharing his extensive knowledge of economics and life experience.

    From the bottom of our hearts and the entire university, we would like to wish Georgy Borisovich good health, many years of productive scientific life, work activity and pleasant rest in moments of peace.

    Subscribe to the TG channel “Our GUU” Date of publication: 05/08/2025

    Please note: This information is raw content directly from the source of the information. It is exactly what the source states and does not reflect the position of MIL-OSI or its clients.

    MIL OSI Russia News –

  • MIL-OSI Banking: New BSTDB Vice President Banking Assumes Duties

    Source: Black Sea Trade and Development Bank

    Press Release | 08-May-2025

    Mr. Aliyev to Lead Banking Operations and Lending Strategy

    Following a nomination by the Republic of Azerbaijan, Mr. Ziya Aliyev assumed today his duties as the new Vice President Banking of the Black Sea Trade and Development Bank (BSTDB). In his role, he will oversee the Bank’s banking operations, including the development and execution of its lending strategy and client engagement.

    “I am thrilled to join BSTDB  and serve its vital development mandate. I look forward to working under the leadership of President Köksal and alongside my colleagues in the Management Committee  to advance  the Bank’s mission. I am eager to leverage my previous experience to bear for the sustainable development and economic  growth of  the Black Sea region, particularly as we navigate today’s complex challenges.”, said Mr. Aliyev on assuming his duties.

    Prior to joining BSTDB, Mr. Aliyev served as Advisor to the Governor at the Central Bank of the Republic of Azerbaijan, where he provided strategic advice on monetary and exchange rate policy, banking supervision, and capital market regulation. Having started his career at the Central Bank in 2000, he progressively advanced through senior roles in research, monetary policy, and strategic development.  From 2013 to 2025, he held the position of Executive Director, overseeing critical departments including Insurance Supervision, Financial Consumer Protection, Strategic Management, and Risk Management.

    Mr. Aliyev has also made notable contributions to Azerbaijan’s national development initiatives. He co-authored the Strategy for National Education Development, approved by the President of the Republic of Azerbaijan in 2013, and played a supportive role in preparing Azerbaijan 2030: National Priorities on Socio-Economic Development, a strategic policy framework adopted in 2021.

    His contributions to the financial sector were acknowledged with the “Progress” Medal, awarded by the President of the Republic of Azerbaijan.

    He has taught business development and strategic management courses at the Center for Banking Education (2019–2020), and previously lectured on development economics and strategic management at the Azerbaijan State Economic University and ADA University.

    His academic background includes a Master of Arts in Policy Economics from the Center for Development Economics at Williams College (USA), and a Master and Bachelor of Science in Finance & Credit from the Azerbaijan State Economic University.

    Mr. Aliyev is fluent in English, Azerbaijani, Russian and Turkish.

     

    The Black Sea Trade and Development Bank (BSTDB) is an international financial institution established by Albania, Armenia, Azerbaijan, Bulgaria, Georgia, Greece, Moldova, Romania, Russia, Türkiye, and Ukraine. The BSTDB headquarters are in Thessaloniki, Greece. BSTDB supports economic development and regional cooperation by providing loans, credit lines, equity and guarantees for projects and trade financing in the public and private sectors in its member countries. The authorized capital of the Bank is EUR 3.45 billion. For information on BSTDB, visit www.bstdb.org.

     

    Contact: Haroula Christodoulou

    : @BSTDB

    MIL OSI Global Banks –

  • MIL-OSI Asia-Pac: Trip will explore tech opportunities

    Source: Hong Kong Information Services

    Legislative Councillor for the Technology & Innovation Functional Constituency Duncan Chiu believes the Middle East can be a fertile market for Hong Kong tech companies looking to expand overseas.

    Mr Chiu will be part of Chief Executive John Lee’s delegation on a visit to Qatar and Kuwait from Saturday and hopes the trip can provide insights into the two countries’ technology needs. Noting that both countries are reliant on imported technology, he stressed that Hong Kong companies’ strengths in areas such as artificial intelligence, life sciences and chip design mean they have much to offer the Middle Eastern market.

    “I know that some Hong Kong people, especially people I know in the tech sector, they have moved to Qatar and were involved in the operation of the Tech Park (Qatar Science & Technology Park) and other university involvements,” he said. “Qatar is quite keen to have collaboration with Hong Kong and Mainland China in tech collaborations, not just in the purchasing of technology, but also collaboration in research and development.”

    With the Hong Kong Special Administrative Region Government setting up a $10 billion Innovation & Technology Industry-Oriented Fund, Mr Chiu anticipates such funds can open the door to new investment in Hong Kong’s innovation and technology sector from the sizeable sovereign wealth funds in Qatar and Kuwait.

    Mr Chiu also plans to invite stakeholders from Qatar and Kuwait to visit Hong Kong.

    “We have put in a lot of resources and efforts in Hong Kong in building up the tech ecosystem. So, I want to first let them know what has been happening in Hong Kong. And second, I would like to invite them to join our conferences and exhibitions in Hong Kong in August.”

    In the past two years, Mr Chiu has organised return visits to Hong Kong after accompanying the Chief Executive on trips to ASEAN (Association of Southeast Asian Nations) member states.

    He said Hong Kong companies have successfully recruited talent and expanded their operations in Singapore and Indonesia as a result of these exchanges, adding that he hopes to replicate this approach in relation to the Middle East.

    MIL OSI Asia Pacific News –

  • MIL-OSI Russia: Exclusive: China made a major contribution to the victory in the World Anti-Fascist War — expert of the Institute of Geophysical Analysis of the Russian Academy of Sciences

    Translation. Region: Russian Federal

    Source: People’s Republic of China in Russian – People’s Republic of China in Russian –

    Source: People’s Republic of China – State Council News

    Moscow, May 8 /Xinhua/ – China made a great contribution to the overall victory in the World Anti-Fascist War, Ekaterina Zaklyazminskaya, head of the Center for World Politics and Strategic Analysis at the Institute of China and Modern Asia of the Russian Academy of Sciences (ICSA RAS), said in an interview with Xinhua.

    “China really made a big contribution to the victory because it was the field that allowed Japanese aggression to be contained on the Eastern Front,” she said, adding that during the World Anti-Fascist War, China was a “shield” for many other states, including the Soviet Union.

    According to E. Zaklyazminskaya, if it were not for the contribution of the Chinese people, the Japanese army could have advanced further and captured more territories, and even more people would have suffered. “China sacrificed itself, its people,” she emphasized.

    The expert noted that through joint efforts, China and the USSR were able to expel Japanese militarists from Chinese territory and stop Japanese aggression. These were very sad, but at the same time very touching pages of bilateral history, she said.

    Speaking about the proper attitude to the results of the World Anti-Fascist War, E. Zaklyazminskaya emphasized that attempts to distort the historical truth are unacceptable. “We must support the truth about the events of those years, about the events of the Second World War. In no case should we allow the falsification of the events of that time, because we must remember that the victory was achieved with great difficulty. This is our common victory, and it laid the foundations of the modern world,” the expert believes.

    E. Zaklyazminskaya is also confident that the international system with the UN as its core, the formation of which was not easy, must be supported and preserved.

    “It is extremely important that both Russia and China support true multipolarity, true multilateralism,” she stressed, adding that both countries strive to ensure that the voice of developing countries is heard, so that countries of the Global South can conduct independent foreign policies. –0–

    MIL OSI Russia News –

  • MIL-OSI China: UN General Assembly holds special meeting to mark 80 years since end of WWII

    Source: People’s Republic of China – State Council News

    Fu Cong, China’s permanent representative to the United Nations, speaks during a special solemn meeting in commemoration of all victims of World War II at the UN headquarters in New York on May 7, 2025. [Photo/Xinhua]

    The United Nations General Assembly (UNGA) on Wednesday convened a special solemn meeting in commemoration of all victims of World War II, as the international community marks the 80th anniversary of the war’s end.

    China, which won the war in the major Oriental theater of WWII, endured casualties exceeding 35 million, said Fu Cong, China’s permanent representative to the United Nations, emphasizing China’s role in the global victory over fascism.

    “By holding back the main forces of Japanese militarism, China not only secured its own survival and national salvation, but also provided strong support to the resistant forces in Europe and the Pacific, making an indelible contribution to the victory of the World Anti-Fascist War,” said Fu.

    Fu said that 80 years later, the world has entered a new period of turbulence and change, with unilateralism on the rise and bullying running rampant.

    Fu called for jointly promoting “a correct understanding of the history of WWII.” “Any scheme or action seeking to downplay, deny, or distort the history of WWII and any rhetoric that glorifies wars of aggression and colonial rule tantamount to a mockery of history and an affront to human conscience, and will surely lose the trust of the global community,” he said.

    “We must firmly uphold the UN-centered international system, the international order based on international law, and the rules-based multilateral trading system, and unequivocally say no to all forms of power politics and bullying,” he said.

    He also called for jointly upholding the authority and status of the United Nations.

    “Certain countries treat the UN as something they can use when it suits them and discard when it doesn’t. They willfully withdraw from agreements and organizations, default on contribution payments, and cut funding in an attempt to place their narrow interests over the collective global good,” Fu said, adding that such practices are “deeply unpopular and are ultimately doomed to failure.”

    Vassily Nebenzia, Russia’s permanent representative to the United Nations, said the victory came at the cost of millions of people.

    “China lost 35 million people. The United States, approximately half a million. Serbia organized the largest partisan movement in Europe. The struggle for the freedom of the peoples was carried out by heroes from Latin America, Asia, and Africa. The cost for the Soviet Union was 27 million people. Twelve million of them were military losses,” Nebenzia said.

    “We will forever remember the great feat that was achieved by the Soviet people, the participants of these historic events. This was a time that was exceedingly difficult, but it was very sacred. A person who experiences significant trials and who vanquishes this will forever draw strength from this victory,” he said.

    Antje Leendertse, Germany’s permanent representative to the United Nations, said the war, unleashed by Nazi Germany, caused immeasurable suffering, in Europe and beyond.

    “That legacy of pain, destruction, and loss will forever be tied to my country’s name. We carry this burden with humility and a moral responsibility, and we accept it without hesitation,” she said.

    “‘Never again’ is not only a commitment for Germany. It is a universal obligation — one that binds us all. An obligation to save succeeding generations from the scourge of war. To protect civilian lives and defend the vulnerable. To uphold the dignity of every human being. And to safeguard the principles of the United Nations Charter for all, including future generations,” said Leendertse.

    Stavros Lambrinidis, head of the European Union Delegation to the United Nations, said it is the occasion to “honor the sacrifices made and mourn the countless lives lost during and after the war.”

    “It is also an opportunity to reiterate our commitment to collaborating with all Member States of the United Nations to ensure a more peaceful, equitable, and prosperous future for generations to come,” Lambrinidis said.

    He said that 80 years on from the end of the Second World War, “we are reminded of the solemn responsibility entrusted to us: to remain true to our collective commitment to uphold the principles of the UN Charter and to ensure that the horrors of war are never repeated.”

    Philemon Yang, president of the UNGA, said in his remarks: “On this 80th anniversary of the end of the Second World War, we reflect on the immense sacrifices made by the millions who fought and died to secure the freedoms we too often take for granted.”

    “As time passes, these commemorations take on a deeper meaning. Most surviving veterans are now centenarians… Preserving their stories is not only a tribute to them, it is a moral responsibility for us all. We must ensure that the lessons they leave behind do not fade but endure,” he said.

    Yang called on world leaders “to choose dialogue over conflict. Diplomacy over escalation. Cooperation over division. Peace over the absence of peace.”

    “We stand at a defining moment — not only for this institution, but for humanity,” said the UNGA president.

    In March, the UNGA passed a resolution to mark the 80th anniversary of the end of World War II. The resolution calls for a special commemorative meeting to be held in the second week of May 2025, and every five years thereafter, to honor the victims of the war.

    It was introduced by Russia, China, Belarus, Azerbaijan, Armenia, Kazakhstan, Kyrgyzstan, Serbia, Tajikistan, Turkmenistan, and Uzbekistan.

    Fu Cong (on the screen), China’s permanent representative to the United Nations, speaks during a special solemn meeting in commemoration of all victims of World War II at the UN headquarters in New York on May 7, 2025. [Photo/Xinhua]

    Vassily Nebenzia, Russia’s permanent representative to the United Nations, speaks during a UN General Assembly’s special solemn meeting in commemoration of all victims of World War II at the UN headquarters in New York on May 7, 2025. [Photo/Xinhua]

    MIL OSI China News –

  • MIL-OSI USA: Padilla, Moran Introduce Bipartisan Bill to Bolster U.S. STEM Leadership, Address Financial Insecurity for Graduate and Postdoctoral Researchers

    US Senate News:

    Source: United States Senator Alex Padilla (D-Calif.)

    Padilla, Moran Introduce Bipartisan Bill to Bolster U.S. STEM Leadership, Address Financial Insecurity for Graduate and Postdoctoral Researchers

    WASHINGTON, D.C. — Today, U.S. Senators Alex Padilla (D-Calif.) and Jerry Moran (R-Kan.) introduced bipartisan legislation to bolster U.S. leadership in STEM by requiring federal research agencies to help address the financial insecurity crisis among graduate and postdoctoral researchers. The Relieving Economic Strain to Enhance American Resilience & Competitiveness in Higher Education & Research (RESEARCHER) Act would also commission studies to better understand the landscape of financial insecurity for these researchers and improve the STEM career pipeline.
    The scientific workforce is fueled by our graduate and postdoctoral researchers making groundbreaking discoveries and technological innovations that help protect American global competitiveness. However, these young researchers face significant financial stressors — including food insecurity, student loan debt, housing costs, and child care costs — that threaten to force many of them to drop out of the STEM pipeline entirely.
    In a 2023 “Postdoctoral Barriers to Success” survey, nearly 95 percent of postdoctoral researchers reported that their salary negatively affected their professional or personal lives, with 85 percent indicating that a lack of benefits was harming their careers. In California, the percentage of University of California graduate students facing food insecurity has increased dramatically in recent years, from 21 percent in 2021 to 35 percent in 2023.
    “As a mechanical engineer, I know a strong STEM workforce pipeline is essential to securing America’s global leadership and promoting lifesaving scientific and technological innovation. But rising costs of living and insufficient salaries are forcing graduate and postdoctoral researchers to look toward other careers,” said Senator Padilla. “The current system is unsustainable for researchers in California and across the country. Our bipartisan bill would help address and improve our understanding of the widespread challenges young researchers face — like food insecurity, student loan debt, health, housing, and child care — to support the researchers who will guide the future of our scientific enterprise.”
    “To remain globally competitive, it is critical that our nation is supporting and prioritizing STEM education and research,” said Senator Moran. “Recent reports demonstrate that financial insecurity is a major barrier for postdoctoral research. This legislation will help equip universities with the tools to better support the success of STEM students in higher education and encourage postdoctoral researchers to pursue a degree in the Midwest.”
    “Although a vital part of the scientific enterprise, graduate students and postdoctoral researchers have endured insufficient support to sustain their most basic needs while doing innovative science.  The Relieving Economic Strain to Enhance American Resilience and Competitiveness in Higher Education and Research, or RESEARCHER Act, is imperative to addressing these barriers. From increasing access to affordable housing, food and health care to addressing costs of caregiving for family members, this legislation seeks to standardize policies and guidance for the federal government agencies to examine as they provide financial support for the future STEM workforce. The University of California thanks Sen. Padilla for his leadership in introducing the RESEARCHER Act and encourages Congress to pass this important legislation quickly,” said UC Vice President for Research & Innovation Theresa A. Maldonado, Ph.D., P.E.
    “The California State University applauds the introduction of the RESEARCHER Act. Addressing the financial instability faced by graduate and postdoctoral researchers is critical to ensuring a strong and sustainable research workforce. This legislation is an important step toward creating equitable and supportive conditions for the next generation of innovators and scholars,” said Dr. Ganesh Raman, Assistant Vice Chancellor for Research at the California State University.
    “Fair compensation is the issue most frequently raised by postdoctoral researchers nationally,” said Thomas P. Kimbis, executive director and chief executive officer of the National Postdoctoral Association (NPA). “The NPA encourages passage of the RESEARCHER Act to increase understanding of the financial needs of postdocs and graduate students, including locality pay issues, and steps that can be taken to address them.”
    “Graduate students and postdocs are the future of the nation’s STEM workforce, yet we are failing to pay many a competitive, livable wage. The RESEARCHER Act is a first step towards ensuring a continued, thriving U.S. scientific enterprise in an increasingly competitive world,” said Jonathan A. Bagger, American Physical Society CEO.
    “AGU applauds the RESEARCHER Act for working to support our nation’s student and early career scientists.  Science needs us like never before with support and resources. By reducing the financial hardships for graduate and postdoctoral researchers, the bill will help increase participation in STEM fields and help build long-term American leadership and innovation in the sciences,” said American Geophysical Union.
    “Graduate students and postdoctoral researchers have long been the foundation of America’s standing as a global leader in science and technology—often while facing enormous financial uncertainty. The RESEARCHER Act is a vital step toward giving these researchers the stability they deserve to continue pushing the boundaries of knowledge and maintaining U.S. leadership in innovation,” said Michael Espinal and Braden Gilleland, Co-Chairs of Federal Affairs, MIT Graduate Student Council.
    Specifically, the RESEARCHER Act would:
    Require federal research agencies to implement policies to address the financial instability of graduate and postdoctoral researchers based on policy guidelines developed by the White House Office of Science and Technology Policy;
    Increase data collection on the financial instability of graduate and postdoctoral researchers by amending the CHIPS and Science Act and directing the National Science Foundation to award institutions of higher education and nonprofit organizations with grants to research the subject;
    Commission a National Academies of Sciences, Engineering, and Medicine study on the status of graduate and postdoctoral researcher financial insecurity; and
    Direct the Government Accountability Office to report on the implementation of the guidelines enacted by federal research agencies and make recommendations to improve said guidelines.
    The RESEARCHER Act is endorsed by the American Physical Society, American Geophysical Union, American Mathematical Association, National Postdoctoral Association, Association for Women in Science, American Association of Immunologists, University of California, California State University, and the MIT Student Graduate Council.
    As a Massachusetts Institute of Technology (MIT) mechanical engineering graduate and a Commissioner of the bipartisan National Security Commission on Emerging Biotechnology (NSCEB), Senator Padilla has worked to advance U.S. scientific and technological leadership. He recently introduced the bipartisan National Biotechnology Initiative Act of 2025 to set in motion a whole-of-government approach to advancing biotechnology for U.S. national security, economic productivity, and competitiveness. The bill followed the Commission’s release of their major report and action plan, urging Congressional action to protect U.S. national security by bringing the full weight of American innovation to improve and maintain U.S. global leadership in biotechnology.
    Senator Padilla also hosted students and advocates last year to reintroduce the Basic Assistance for Students in College (BASIC) Act, bicameral legislation to help ensure college and university students can better meet their basic needs while pursuing higher education.
    A one-pager on the bill is available here.
    Full text of the bill is available here.

    MIL OSI USA News –

  • MIL-OSI New Zealand: Budget 2025 – Budget priorities supported by business – BusinessNZ

    Source: BusinessNZ

    Continued R&D support and substantial infrastructure investment will figure in the 2025 Budget.
    These were among the Budget priorities outlined by the Prime Minister at BusinessNZ’s Pre-Budget lunch in Auckland today.
    The business audience reacted positively to news of continued Budget provision for the R&D tax incentive (RDTI) that supports innovation investment by firms, and to other investment in science and innovation including the establishment of three new public research organisations.
    Plans to boost spending on pro-growth infrastructure were also well received.
    BusinessNZ Chief Executive Katherine Rich says there is a general understanding in the business community that fiscal discipline by the Government is paramount, given the economic conditions it inherited.
    “There is good support for the Government keeping a tight rein on borrowing and spending, and for investing in growth.
    “The Government’s plans for encouraging science and technology, introducing more competitive business settings, promoting investment, and delivering infrastructure for growth, demonstrate a prudent approach to economic management,” Mrs Rich said.
    The BusinessNZ Network including BusinessNZ, EMA, Business Central, Business Canterbury and Business South, represents and provides services to thousands of businesses, small and large, throughout New Zealand.

    MIL OSI New Zealand News –

  • MIL-Evening Report: ‘These violations should never have occurred’: the troubled history of intercountry adoption

    Source: The Conversation (Au and NZ) – By Samara Kim, PhD Candidate & Researcher, Southern Cross University

    Korean adoptees worldwide are grappling with a devastating possibility: they were not truly orphans, but may have been made into orphans.

    For decades, adoptees were told they were “abandoned”, “rescued” or “unwanted”. Many were told their Korean families were too “poor” or “incapable” to raise them – and they should only ever feel grateful for being adopted.

    But these long-held stories are now under scrutiny.

    Our recent research interrogates the narratives that have obscured the darker realities of intercountry adoption. Rather than viewing adoption solely through the lens of “rescue”, our work examines the broader power structures that facilitated the mass migration of Korean children to western countries, including Australia.

    South Korea’s reckoning with its adoption history

    In March, South Korea’s Truth and Reconciliation Commission released its preliminary findings after collecting records and testimony from a coalition of overseas Korean adoptee-led organisations (including the Australia–US Korean Rights Group).

    The preliminary report revealed a disturbing pattern of human rights violations in the country’s adoption industry, including:

    • forced relinquishments
    • falsified records
    • babies switched at adoption
    • inadequate screening processes, and
    • deep-rooted institutional corruption.

    The commission’s chair described finding

    serious violations of the rights of adoptees, their biological parents – particularly Korean single mothers – and others involved. These violations should never have occurred.

    The commission is expected to release its final report soon, but due to the upcoming presidential election and political uncertainty in South Korea, the timeline remains unclear.

    Chilling cases

    This is not the first time intercountry adoption has made headlines for irregularities, human rights abuses, or illicit and illegal practices.

    While Australia was expanding the number of children for intercountry adoption from South Korea in the 1980s, Park In-keun – director of South Korea’s infamous Brothers Home, an illegal detention facility that sent children overseas for adoption – was arrested for embezzlement and illegal confinement.

    He was ultimately acquitted of the most serious charges in South Korea before escaping to Australia. He was then charged again in 2014 for embezzlement, including government subsidies and wages of inmates forced into slave labour in South Korea. He died two years later.

    Other allegations of human rights violations and abuses came to light around the same time with the arrest of Julie Chu.

    She was accused of facilitating a “baby export” syndicate. Children were believed to have been kidnapped from Taiwan to send to Western countries, including Australia, in the 1970s and 80s. She was convicted of forgery, but denied being involved in trafficking.

    Since then, other cases have continued to emerge involving countries such as Chile, Sri Lanka, India, Ethiopia and Guatemala.

    What is the adoption industrial complex?

    Intercountry adoption is not just a social practice. It’s also an economic and political system sometimes known as the transnational adoption industrial complex.

    This network of organisations, institutions, government policies and financial systems created a globalised adoption economy worth billions of dollars. According to numerous investigations, Western nations, as “receiving” countries, drove the demand for the continuous sourcing of children.

    As Park Geon-Tae, a senior investigator with South Korea’s Truth and Reconciliation Commission, said:

    To put it simply, there was supply because there was demand.

    Australia received an estimated 3,600 Korean children from the 1970s to the present, as part of more than 10,000 intercountry adoptions.

    Prospective parents typically paid between US$4,500 and $5,000 to facilitate acquiring a child in Australia in the 1980s, equivalent to A$21,000 today.

    Since colonisation, Australia has had a long and painful history of child removal. From the Stolen Generations involving First Nations children to the forced adoption of children born to unwed mothers, child separation has been deeply embedded in the nation’s social policy.

    While national apologies have acknowledged the irreparable harms caused by these policies, the same ideologies and structures were repurposed as the blueprint for intercountry adoption.

    In recent years, other western nations, such as Denmark, Norway, the Netherlands, Sweden and Switzerland, have begun to investigate their own roles in the intercountry adoption industry. These nations have either suspended their adoption programs, issued formal apologies or launched formal investigations.

    Thus far, Australia and the United States have not.

    Challenging the ‘rescue’ myth

    Intercountry adoption has long been framed as a humanitarian act. The central idea was that children needed “rescuing” and any life in a Western country would be “better” than one with their families in their home country.

    Many adoptees and their original families were expected to just move on or be grateful for being “saved”.

    However, research shows this gratitude narrative disregards the deep trauma caused by forced separation.

    Studies have reported that adoptees experience lifelong ruptures due to cultural, familial and ancestral displacement. Forced assimilation makes reconnection with family and culture complex or nearly impossible.

    Many intercountry adoptees have also voiced concerns about abuse, violence and mistreatment in adoptive homes.

    Questioning the ‘orphan crisis’ myth

    The myth of a global orphan crisis has also been a powerful driver of intercountry adoption.

    Adoption groups often reference outdated UNICEF estimates that there are 150 million orphans globally. However, this figure obscures the fact most of the children classified as “orphans” are children of single parents, or children currently living in homes with extended family or other caregivers.

    This was the case in South Korea. Most children sent for adoption were not true orphans, but children who had at least one parent or extended family they could have stayed with if they were adequately supported.

    The belief that millions of children of single parents were “orphans” in need of “rescue” was used to justify calls for faster, less regulated adoptions.

    Labelling these children as “orphans” also helped attract millions of dollars in philanthropic donations. However, donors were rarely interested in supporting children to stay with their families and communities in their home countries.

    Instead, the focus was often on removing and migrating them for the purpose of intercountry adoption.

    The question then emerges: was this about finding families for babies or finding babies for Western families?

    Samara Kim is a founding member of KADS Connect, an advocacy organisation for South Korean adoptees.

    Kathomi Gatwiri and Lynne McPherson do not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and have disclosed no relevant affiliations beyond their academic appointment.

    – ref. ‘These violations should never have occurred’: the troubled history of intercountry adoption – https://theconversation.com/these-violations-should-never-have-occurred-the-troubled-history-of-intercountry-adoption-254200

    MIL OSI Analysis – EveningReport.nz –

  • MIL-OSI New Zealand: PM’s Science Prizes celebrate excellence

    Source: NZ Music Month takes to the streets

    Some of New Zealand’s most outstanding scientific minds have been recognised at the 2024 Prime Minister’s Science Prizes Award Ceremony, held this evening in Wellington.

    Prime Minister Christopher Luxon praised the winners, acknowledging the crucial role that science plays in building a more productive, innovative, and sustainable New Zealand.

    “This year’s top honour, the Prime Minister’s Science Prize, has been awarded to Dr Linda Johnson and the Endophyte Discovery Team at AgResearch,” Christopher Luxon says. 

    “Their groundbreaking work to improve the health and productivity of ryegrass is making a tangible difference for New Zealand farmers, boosting yields while reducing reliance on pesticides.”

    Ryegrass is the most commonly used pasture grass in New Zealand agriculture. The team’s research has led to the development of beneficial microorganisms that protect grass from pests and disease, while also enhancing drought resistance.

    “This is an excellent example of science delivering real-world solutions.

    “By improving the quality of pasture on our farms, we’re not only increasing our capacity to produce high-quality food, but we’re also supporting the growth of our economy and ensuring a more resilient future for our agricultural sector.”

    The Prime Minister’s Science Prizes comprise five prestigious awards, with a total prize pool of $975,000. The 2024 recipients include:

    • Dr Olivia Harrison, University of Otago – awarded the MacDiarmid Emerging Scientist Prize for her multidisciplinary work in understanding and managing anxiety.
    • Dr Aiden Kiely, Aorere College, Auckland – awarded the Science Teacher Prize for his dedication to equity and excellence in science education.
    • Professor Jemma Geoghegan, University of Otago – awarded the Science Communication Prize for advancing public understanding of infectious diseases and guiding policy responses to pandemic threats in New Zealand and the Pacific.
    • Rena Misra, Epsom Girls’ Grammar School – awarded the Future Scientist Prize for her innovative research into using fungi to improve stormwater filtration systems.

    “Congratulations to all this year’s winners. Your achievements are a testament to the power of Kiwi ingenuity and scientific excellence,” Mr Luxon says. 

    “Your work is not only advancing knowledge—it’s improving lives and building a better New Zealand for future generations.”

    The five prizes are: 

    The Prime Minister’s Science Prize

    An individual or team for a transformative scientific discovery or achievement, which has had a significant economic, health, social and/or environmental impact on New Zealand and/or internationally. The total value of this prize is $500,000. $100,000 goes towards the team, and $400,000 will be used to support the ongoing research.

    The Prime Minister’s MacDiarmid Emerging Scientist Prize

    An outstanding emerging scientist who has had their PhD or equivalent qualification conferred within the last eight years i.e. (no earlier than 1 January 2014). The total value of the Prize is $200,000. $50,000 is for the winner, and $150,000 for their ongoing research. 

    The Prime Minister’s Science Teacher Prize

    A registered teacher kaiako who has been teaching science, mathematics, technology, pūtaiao, hangarau or pāngarau learning areas of the New Zealand curriculum to school-age children in a primary, intermediate or secondary New Zealand registered school or kura kaupapa. The total value of this prize is $150,000. The winner can use $50,000 at their own discretion. The winner’s school will receive $100,000 which must be used for the development of science in their school.

    The Prime Minister’s Science Communication Prize

    A practising scientist who can demonstrate an interest, passion and aptitude for science communication and public engagement, or to a person who has developed expertise in public engagement, or communication of complex scientific or technological information to the public and/or science and research communities. The total value of the Prize is $75,000. $55,000 of the Prize money is to be used to support the recipient to carry out a programme of activities/professional development to further their understanding of science communication.  $20,000 is for the winner.

    The Prime Minister’s Future Scientist Prize

    Awarded to a Year 12 or Year 13 school tauira student for outstanding achievement in carrying out a practical and innovative science research, maths, technology or engineering project. This Prize is valued at $50,000 and is to be used to support the winner’s tertiary education.

    MIL OSI New Zealand News –

  • MIL-OSI New Zealand: PM’s Science Council to set direction for science

    Source: NZ Music Month takes to the streets

    Prime Minister Christopher Luxon has today announced the new Prime Minister’s Chief Science Advisor, and the members of the Prime Minister’s Science and Technology Advisory Council.

    “We have world-class scientists in our universities and research institutes, but they’re working in a system held back by outdated settings. To unlock the full potential of science and technology, we need a sharper focus on commercialisation, better access to global investment, and clearer priorities at home,” Mr Luxon says. 

    “This Council is a new initiative to get clear, independent advice to ensure our investments in science and technology are delivering real outcomes for New Zealanders.

    “The Council will provide advice on long-term priorities for government-funded science and innovation. They will help identify areas of focus that will have the greatest benefit for Kiwis and our economy. 

    “I also expect them to provide bold and courageous advice about those areas that aren’t delivering value for New Zealanders and may need to be deprioritised. It’s about making sure we are investing in what will have the greatest impact for New Zealanders.”

    Members of the Council bring a strong mix of scientific, commercial and strategic expertise. They include:

    Sir Peter Gluckman
    Craig Piggott
    Professor Merryn Tawhai
    Komal Mistry-Mehta
    Malcolm Johns
    Dr John Roche

    “I am also pleased to announce that Dr John Roche has been appointed as the Prime Minister’s Chief Science Advisor. In this role, John will support robust decision making by providing high quality, independent scientific advice. John, in his capacity as my science advisor, will also be a member of the council.”

    Minister for Science, Innovation and Technology, Hon Dr Shane Reti, will chair the Council, with Dr John Roche as deputy chair.

    “These are highly capable individuals who understand both the science and the economic imperatives. They are prepared to make the bold calls needed to ensure the system is future-focused, outcome-driven and aligned with our economic goals,” Mr Luxon says.

    “A strong, well-directed science and innovation sector is critical to lifting productivity, creating high-value jobs and supporting a more resilient and competitive economy.”

    The Council will provide its first formal advice to the Prime Minister and Minister Reti later this year.

    Biographies of Council members:

    Sir Peter Gluckman 
    Professor Sir Peter Gluckman ONZ KNZM FRSNZ FMedSci FRS trained as a paediatrician and biomedical scientist. He is Director of Koi Tu- Centre for Informed Futures and holds a Distinguished University Professorship at the University of Auckland. He is currently the chair of the Science System Advisory Group. Sir Peter is President of the International Science Council (ISC, 2021-2026). From 2014-2021 he was the inaugural Chair of the International Network of Government Science Advice (INGSA), and from 2009-2018 he was the first Chief Science Advisor to the Prime Minister of New Zealand. He was also Science Envoy for the New Zealand Ministry of Foreign Affairs and Trade and coordinated the secretariat of the Small Advanced Economies Initiative. He has written and spoken extensively on science-policy and science-diplomacy and science-society interactions. He has received the highest scientific and civilian honours in New Zealand and numerous international scientific awards. 
    Craig Piggott
    Craig Piggott is the founder of Halter. The company’s solar-powered collar for dairy and beef cows, pairs with an app for farmers and allows cows to respond to guidance cues, enabling virtual herding and fencing while monitoring health 24/7. This innovation helps farmers increase milk and protein production propelling the company to become one of New Zealand’s fastest-growing businesses with a thriving international customer base. Craig brings experience in innovation, agriculture and business.  
    Merryn Tawhai
    Merryn Tawhai graduated from the University of Auckland with a PhD in Engineering Science in 2001. She leads a research programme at the Auckland Bioengineering Institute (ABI) in applied computational physiology of the respiratory system. Merryn is the Director of the ABI and sits on the Board of Directors for Cure Kids Ventures and the Virtual Physiological Human Institute. She was ABI’s Deputy Director for 10 years, Director of the Medical Technologies Centre of Research Excellence (MedTech CoRE), and an independent Director for Izon Science. Merryn was awarded the 2016 MacDiarmid Medal by the Royal Society of New Zealand (RSNZ) Te Apārangi, is a Fellow of the RSNZ, a Fellow of IAMBE and AIMBE, and an elected member of the Fleischner Society.
    Komal Mistry-Mehta
    Komal is Chief Innovation & Brand Officer at Fonterra and Managing Director of the Ki Tua Fund, Fonterra’s corporate venture capital arm. She leads global innovation, research and development, digital, brand and marketing functions for New Zealand’s largest company. Prior to joining the Fonterra Executive Team, Komal led Fonterra’s global health and nutrition business based in Singapore. With experience across Asia, the America’s and Europe, she has led major transformations in sales, innovation, digital enablement and technology. Komal was named New Zealand’s Young Executive of the Year in 2017 and serves on several international boards. Komal has completed the Executive Program at Stanford University School of Business and holds Bachelor of Laws and Bachelor of Management degrees from the University of Waikato. She is a Barrister and Solicitor of the High Court of New Zealand as well as a member of the New Zealand Institute of Chartered Accountants.
    Malcolm Johns
    Malcolm is the Chief Executive of Genesis Energy. Previously he was the Chief Executive of InterCity Group and held several governance roles within New Zealand’s transport, infrastructure and tourism sectors. He is Convenor of the Climate Leaders Coalition and served as Chair of the APEC Business Advisory Council leading the regional trade policy task force for climate change. Malcolm has extensive business acumen and understanding of Government systems

    John Roche 
    John was appointed MPI’s Chief Science Adviser in June 2018 to provide an independent science perspective. He leads MPI’s Science Forum, chairs the Science Governance Group at MPI and the independent Mycoplasma bovis Strategic Science Advisory Group. John is also a member of the Prime Minister’s Chief Science Adviser’s forum and is an adjunct professor in University of Auckland’s School of Biological Sciences. John was previously DairyNZ’s Principal Scientist for Animal Science. He has held science appointments in Ireland and Australia. He is also Managing Director of Down to Earth Advice Ltd. Widely published and a regular contributor to international science and farming conferences, John has an Honours degree in Agricultural Science, a Masters in Farm Systems and Pasture Management, and a PhD in Animal Nutrition.

    MIL OSI New Zealand News –

  • MIL-Evening Report: ER Report: A Roundup of Significant Articles on EveningReport.nz for May 8, 2025

    ER Report: Here is a summary of significant articles published on EveningReport.nz on May 8, 2025.

    Women’s sports are fighting an uphill battle against our social media algorithms
    Source: The Conversation (Au and NZ) – By Hans Westerbeek, Professor of International Sport Business, Head of Sport Business Insights Group, Victoria University Women’s sport is more and more getting the attention it deserves. Stadiums are filling, television ratings for many sports are climbing and athletes such as the Matildas’ Mary Fowler, triple Olympic gold

    New taxes on super didn’t get much attention in the election campaign. But they could be tricky to implement
    Source: The Conversation (Au and NZ) – By Mark Melatos, Associate Professor of Economics, University of Sydney Poetra.RH/Shutterstock The re-election of the Albanese government has led to renewed concern about planned changes to the taxation of investment returns in superannuation funds. Labor’s emphatic victory on Saturday night, including what looks like an increased presence in

    New Caledonia’s political talks – no outcome after three days of ‘conclave’
    By Patrick Decloitre, RNZ Pacific correspondent French Pacific Desk After three solid days of talks in retreat mode, New Caledonia’s political parties have yet to reach an agreement on the French Pacific territory’s future status. The talks, held with French Minister for Overseas Manuel Valls and French Prime Minister’s special advisor Eric Thiers, have since

    Forest home of ‘polar dinosaurs’ 120 million years ago in southern Australia recreated in detail for the first time
    Source: The Conversation (Au and NZ) – By Vera Korasidis, Lecturer in Environmental Geoscience, The University of Melbourne Artwork © Bob Nicholls 2024 Roughly 140 million to 100 million years ago, the piece of land that is modern day Australia was located much further south on Earth. In fact, what is now Victoria was once

    Ovarian cysts can be painful when they burst. When do you need to see a doctor?
    Source: The Conversation (Au and NZ) – By Anna Chruścik, Lecturer in Biomedical Sciences, University of Southern Queensland PeopleImages.com – Yuri A/Shutterstock Cysts are small pockets of fluid that form inside the body. Ovarian cysts are common, affecting around one in ten women. But sometimes they can cause pain – especially when they burst. You

    Keith Rankin Chart Analysis – International Trade over time: gifts with strings
    Analysis by Keith Rankin. The ‘see-saw’ chart above shows the accumulated ‘excess benefits’ that Aotearoa New Zealand, and a few other countries, have enjoyed from international trade over the last 40 years. These are benefits arising from ‘unbalanced trade’ which are in addition to the regular benefits – arising from efficient specialisation – of ‘balanced’

    ‘Utu’ as foreign policy: how a Māori worldview can make sense of a shifting world order
    Source: The Conversation (Au and NZ) – By Nicholas Ross Smith, Senior Research Fellow, National Centre for Research on Europe, University of Canterbury Getty Images There is a growing feeling in New Zealand that the regional geopolitical situation is becoming less stable and more conflicted. China has ramped up its Pacific engagement, most recently with

    While the Liberals haemorrhaged, the Nationals held their own. Is it time to break up the Coalition?
    Source: The Conversation (Au and NZ) – By Linda Botterill, Visiting Fellow, Crawford School of Public Policy, Australian National University Among the notable features of this year’s election campaign was that Australia’s second-oldest political party was apparently missing in action. At the same time, it managed to avoid the rout inflicted on its coalition partner.

    Why is hospital parking so expensive? Two economics researchers explain
    Source: The Conversation (Au and NZ) – By Lisa Farrell, Professor of Economics (Health Economist), RMIT University ThirtyPlus/Shutterstock Imagine having to pay A$39 dollars a day to park your car while visiting your sick child in hospital. For families already struggling in a cost-of-living crisis, hospital parking fees are not just another expense. They can

    Vietnam is poised to become a top 20 economy, so why is Australia taking so long to make trade and investment links?
    Source: The Conversation (Au and NZ) – By Anne Vo, Senior lecturer in Vietnamese culture and politics, University of Wollongong Aritra Deb/Shutterstock At a time of widespread global trade instability, Australia should be expanding and diversifying its economic partnerships. Supply chains remain fragile, and protectionist rhetoric is once again gaining traction in major Western economies.

    Marvel’s Thunderbolts* shines a light on men’s mental illness – but falls down with this outdated plotline
    Source: The Conversation (Au and NZ) – By Emily Baulch, Research Associate, Discipline of Media and Communications, University of Sydney Marvel Studios This piece contains spoilers. Marvel’s men are sad. And that’s a good thing. Thor’s depressed in Avengers: Endgame. Tony Stark has panic attacks in Iron Man 3. Peter grieves in Spider-Man: No Way

    Australia is set to be a renewables nation. After Labor’s win, there’s no turning back
    Source: The Conversation (Au and NZ) – By Wesley Morgan, Research Associate, Institute for Climate Risk and Response, UNSW Sydney bmphotographer/Shutterstock An emphatic election victory for the incumbent Labor government means Australia’s rapid shift to renewable energy will continue. As Climate Change and Energy Minister Chris Bowen said on Saturday: In 2022, the Australian people

    Financial Times: The West’s shameful silence on Gaza – do more to restrain Benjamin Netanyahu
    EDITORIAL: The Financial Times editorial board After 19 months of conflict that has killed tens of thousands of Palestinians and drawn accusations of war crimes against Israel, Benjamin Netanyahu is once more preparing to escalate Israel’s offensive in Gaza. The latest plan puts Israel on course for full occupation of the Palestinian territory and would

    ‘Under no illusions’ about France, says author of new Rainbow Warrior book
    Pacific Media Watch The author of the book Eyes of Fire, one of the countless publications on the Rainbow Warrior bombing almost 40 years ago but the only one by somebody actually on board the bombed ship, says he was under no illusions that France was behind the attack. Journalist David Robie was speaking last

    Australia doesn’t have a federal Human Rights Act – but the election clears the way for overdue reform
    Source: The Conversation (Au and NZ) – By Amy Maguire, Professor in Human Rights and International Law, University of Newcastle Master1305/Shutterstock The Albanese government has achieved an historic re-election, substantially building its majority in the House of Representatives. Much has already been written about the potential for a more ambitious legislative program on the back

    Samoa down in RSF media freedom world ranking due to ‘authoritarian pressure’
    Talamua Online News Samoa has dropped in its media and information freedom world ranking from 22 in 2024 to 44 in 2025 in the latest World Press Freedom Index compiled annually by the Paris-based Reporters Without Borders (RSF). For the Pacific region, New Zealand is ranked highest at 16, Australia at 29, Fiji at 40,

    How maximum security prison inmates and officers worked together to create a farm behind bars
    Source: The Conversation (Au and NZ) – By Christian Tietz, Senior Lecturer in Industrial Design, UNSW Sydney Macquarie Correctional Centre Media Unit At Macquarie Correctional Centre in western New South Wales, a story of collaboration and persistence is unfolding. Inmates and prison officers are farming commercial quantities of fresh food in a purpose-built indoor facility.

    Can what you eat during pregnancy and breastfeeding affect whether your child develops food allergies?
    Source: The Conversation (Au and NZ) – By Jennifer Koplin, Evidence and Translation Lead, National Allergy Centre of Excellence; Chief Investigator, Centre of Food Allergy Research; Associate Professor and Group Leader, Childhood Allergy & Epidemiology Group, Child Health Research Centre, The University of Queensland Maria Evseyeva/Shutterstock Many questions pop up when you’re growing or raising

    How do you put a tariff on movies? Here’s what Trump’s plan could mean for Australia
    Source: The Conversation (Au and NZ) – By Mark David Ryan, Professor, Film, Screen, Animation, Queensland University of Technology Kirk Wester/Shutterstock US President Donald Trump’s recent announcement of a plan to impose a 100% tariff on movies “produced in foreign lands” could have a massive impact on the global entertainment industry. Film and television production

    Labor says its second term will be about productivity reform. These ideas could help shift the dial
    Source: The Conversation (Au and NZ) – By Roy Green, Emeritus Professor of Innovation, University of Technology Sydney Summit Art Creations/Shutterstock In his victory speech, Prime Minister Anthony Albanese highlighted social policy as a major factor in Labor’s electoral success, particularly Medicare, housing and cost of living relief. He was justified in doing so. But

    MIL OSI Analysis – EveningReport.nz –

  • MIL-OSI China: Why historical truth of WWII should never be distorted

    Source: People’s Republic of China – State Council News

    Aircraft fly in formation over Red Square during a rehearsal for the Victory Day military parade, which marks the 80th anniversary of the Victory in the Great Patriotic War, in Moscow, Russia, May 5, 2025. (Xinhua/Zhai Jianlan)

    This year marks the 80th anniversary of victory in World War II (WWII). Chinese President Xi Jinping travels to Russia on Wednesday for a state visit and celebrations marking the 80th anniversary of the Victory in the Soviet Union’s Great Patriotic War.

    The commemoration stands as a powerful reminder of the brutality of war, the precious hard-won peace and stability, and the importance of historical truth — especially at a time when the world is grappling with a resurgence in unilateralism, economic coercion and hegemonic mentality.

    What is alarming is that in recent years, there have been repeated attempts to distort or deny the legacy of the WWII victory. These attempts, drawing widespread criticism and concern, have reminded the world of the necessity to safeguard the integrity of the history of WWII.

    WHO IS DISTORTING WWII HISTORY?

    In these years, politicians from certain countries have sought to achieve political gains by manipulating historical truth.

    “We are witnessing increasing efforts to rehabilitate Nazism and racial supremacy, glorify Nazis and their collaborators, and revive practices of racial discrimination, xenophobia and related intolerance,” Russian Foreign Ministry spokeswoman Maria Zakharova told Xinhua in a recent interview.

    In March, U.S. Secretary of Defense Pete Hegseth, while attending a memorial service on Iwo Jima to honor those who died in one of WWII’s pivotal battles, claimed Japan as being indispensable in tackling “Chinese aggression” and complimented the “valor” of Japanese soldiers.

    Hegseth’s remarks sparked sharp criticism, with many viewing them as an attempt to whitewash Japan’s militarism during WWII. His comments were also seen as a betrayal of those who sacrificed their lives in anti-fascist fight.

    Such attempts to distort or deny the history of the World Anti-Fascist War are not new.

    After WWII, as the Cold War between the United States and the Soviet Union intensified, Washington chose to support Japan as a strategic counterweight in Asia. In doing so, the remnants of Japanese fascism were not fully eradicated.

    Until this day, some right-wing Japanese politicians still refuse to renounce Japan’s militaristic past, and even question or deny the outcomes of the war.

    They continue to pay tribute to the notorious Yasukuni Shrine, which honors 14 convicted Class-A Japanese WWII war criminals, revise high school history textbooks to downplay Japan’s wartime atrocities, and deny the forced recruitment of “comfort women” by the Japanese military during WWII.

    “In recent years, Japan has recklessly tampered with textbooks, and the theory of no guilt for aggression has a relatively large market in Japan,” said Sun Huixiu, an associate professor with the School of History at Beijing Normal University.

    Similar historic revisionism took place in the West. There have been attempts by some Western countries to downplay or even completely deny the role of the Red Army and the Soviet people in the victory over Nazism.

    A survey conducted by IFOP, an international market research group, in May 1945 showed that 57 percent of French people credited the Soviet Union with having made the greatest contribution to Nazi defeat, compared to just 20 percent backing the United States and 12 percent Britain.

    However, by 2018, a YouGov survey showed a dramatic shift in public perception: 56 percent of the French believed the United States played the most important role, 11 percent credited Britain, and only 15 percent recognized Russia’s contribution.

    WHY HISTORICAL TRUTH SO IMPORTANT?

    During the deadliest military conflict in human history 80 years ago, more than 80 countries and regions, involving roughly 2 billion people, were drawn into the war. More than 100 million worldwide were killed or wounded, and global economic losses exceeded 4 trillion U.S. dollars.

    To resist fascist aggression, more than 50 countries, including China and the Soviet Union, formed a united front. As the main theater in the East during the World Anti-Fascist War, China paid a heavy price — over 35 million casualties in its fight against the majority troops of Japanese militarism.

    A woman visits the site used to be a bacterial laboratory at the former site of the Unit 731 in Harbin, northeast China’s Heilongjiang Province, Dec. 13, 2024. (Xinhua/Xie Jianfei)

    Preserving the truth of history is the most meaningful tribute to the soldiers and civilians who perished during WWII. It is also a foundation for reconciliation between former belligerent nations.

    “How should we respond to the sin of the Holocaust for which we should take responsibility? Summing up the past can be a prerequisite to reconciliation,” said former German Chancellor Angela Merkel during her visit to Japan in 2015.

    More importantly, as noted by Xi at the general debate of the 70th session of the UN General Assembly back in 2015, history is a mirror, and only by drawing lessons from history can the world avoid repeating past calamities.

    After WWII, the Allied powers carried out the Nuremberg and Tokyo Trials, which marked the first time in human history that war criminals were prosecuted before an international tribunal, delivering rightful punishment, upholding international justice and sending a powerful warning to fascist forces.

    Based on the WWII victory, key members of the anti-fascist alliance jointly initiated the founding of the United Nations and formulated a series of important international documents including the Cairo Declaration, the Potsdam Proclamation and the Charter of the United Nations, which laid the foundation for the modern international order and established the basic norms governing contemporary international relations.

    “These instruments helped to hold fascist crimes accountable, and through a series of institutional frameworks, effectively placed a ‘security lock’ on the postwar world to help preserve peace,” said He Lei, former vice president of the Academy of Military Science of the Chinese People’s Liberation Army, in an article.

    Since the end of WWII, the world has witnessed a level of global prosperity unprecedented in human history thanks to the largely peaceful era it has been in. “We need to firmly remember the history of WWII and maintain the world political and economic order,” said Sun.

    “Today, it seems no one disputes that the victory over fascism and militarism was one of humanity’s greatest achievements in the 20th century,” said Kirill Babayev, director of the Institute of China and Modern Asia at the Russian Academy of Sciences.

    This underscores that Russia and China must remain at the forefront of preserving this memory, he noted.

    “In the global agenda, we must uphold a position that demands full respect for historical truth, rejects its distortion, and, above all, safeguards the memory of those who perished during World War II while defending our freedom,” he added.

    MIL OSI China News –

  • MIL-OSI USA: NASA Statement on Nomination of Matt Anderson for Deputy Administrator

    Source: NASA

    Acting NASA Administrator Janet Petro issued the following statement regarding the nomination by President Donald Trump of Matt Anderson Wednesday to serve as the agency’s deputy administrator:
    “As a retired United States Air Force colonel and executive of the Space Force Association, Matt Anderson brings extensive knowledge of space operations, aeronautics expertise, and industry experience. If confirmed, he would join NASA’s leadership team at a time when partnerships and a sharpened focus on mission are essential to our continued success. Along with President Trump’s nominee to lead NASA, Jared Isaacman, he will strengthen collaboration across sectors and help NASA advance exploration, serve the American people, and deliver results for the benefit of all.”
    Throughout his over 24-year tenure in the U.S. Air Force, Anderson culminated his career as the U.S. Transportation Command’s senior liaison officer to North American Aerospace Defense Command (NORAD), U.S. Northern Command (USNORTHCOM), and U.S. Space Command (USSPACECOM). He retired as a colonel Oct. 1, 2021. Anderson is currently a vice president and Space Force & Air Force client executive at CACI. He also serves as the chief growth officer at the Space Force Association.
    An alum of the U.S. Air Force Academy, Embry-Riddle Aeronautical University, and the University of Colorado at Colorado Springs, Anderson holds degrees in biology, aeronautical science, and leadership & counseling. In 2024, Anderson was named by the Washington Exec as one of their “Top Space Execs to Watch.”
    For more about NASA’s mission, visit:

    Home Page

    -end-
    Bethany Stevens / Amber JacobsonHeadquarters, Washington202-358-1600bethany.c.stevens@nasa.gov / amber.c.jacobson@nasa.gov

    MIL OSI USA News –

  • MIL-OSI USA: Key Portion of NASA’s Roman Space Telescope Clears Thermal Vacuum Test

    Source: NASA

    One half of NASA’s nearly complete Nancy Grace Roman Space Telescope just passed a lengthy test to ensure it will function properly in the space environment. This milestone keeps Roman well on track for its target launch by May 2027, with the team aiming for as early as fall 2026.

    “This milestone tees us up to attach the flight solar array sun shield to the outer barrel assembly, and deployable aperture cover, which we’ll begin this month,” said Jack Marshall, who leads integration and testing for these elements at NASA’s Goddard Space Flight Center in Greenbelt, Maryland. “Then we’ll complete remaining environmental tests for the flight assembly before moving on to connect Roman’s two major assemblies and run the full observatory through testing, and then we’ll be ready to launch!”
    Prior to this thermal testing, technicians integrated Roman’s deployable aperture cover, a visor-like sunshade, to the outer barrel assembly, which will house the telescope and instruments, in January, then added test solar panels in March. They moved this whole structure into the Space Environment Simulator test chamber at NASA Goddard in April.
    There, it was subjected to the hot and cold temperatures it will experience in space. Next, technicians will join Roman’s flight solar panels to the outer barrel assembly and sunshade. Then the structure will undergo a suite of assessments, including a shake test to ensure it can withstand the vibrations experienced during launch.

    Meanwhile, Roman’s other major portion — the spacecraft and integrated payload assembly, which consists of the telescope, instrument carrier, and two instruments — will undergo its own shake test, along with additional assessments. Technicians will install the lower instrument sun shade and put this half of the observatory through a thermal vacuum test in the Space Environment Simulator.
    “The test verifies the instruments will remain at stable operating temperatures even while the Sun bakes one side of the observatory and the other is exposed to freezing conditions — all in a vacuum, where heat doesn’t flow as readily as it does through air,” said Jeremy Perkins, an astrophysicist serving as Roman’s observatory integration and test scientist at NASA Goddard. Keeping the instrument temperatures stable ensures their readings will be precise and reliable.
    Technicians are on track to connect Roman’s two major parts in November, resulting in a complete observatory by the end of the year. Following final tests, Roman is expected to ship to the launch site at NASA’s Kennedy Space Center in Florida for launch preparations in summer 2026. Roman remains on schedule for launch by May 2027, with the team aiming for launch as early as fall 2026.

    To virtually tour an interactive version of the telescope, visit:
    https://roman.gsfc.nasa.gov/interactive
    The Nancy Grace Roman Space Telescope is managed at NASA’s Goddard Space Flight Center in Greenbelt, Maryland, with participation by NASA’s Jet Propulsion Laboratory in Southern California; Caltech/IPAC in Pasadena, California; the Space Telescope Science Institute in Baltimore; and a science team comprising scientists from various research institutions. The primary industrial partners are BAE Systems Inc. in Boulder, Colorado; L3Harris Technologies in Rochester, New York; and Teledyne Scientific & Imaging in Thousand Oaks, California.
    By Ashley BalzerNASA’s Goddard Space Flight Center, Greenbelt, Md.
    ​​Media Contact:Claire AndreoliNASA’s Goddard Space Flight Center301-286-1940

    MIL OSI USA News –

  • MIL-OSI USA: New Visualization From NASA’s Webb Telescope Explores Cosmic Cliffs

    Source: NASA

    In July 2022, NASA’s James Webb Space Telescope made its public debut with a series of breathtaking images. Among them was an ethereal landscape nicknamed the Cosmic Cliffs. This glittering realm of star birth is the subject of a new 3D visualization derived from the Webb data. The visualization, created by NASA’s Universe of Learning and titled “Exploring the Cosmic Cliffs in 3D,” breathes new life into an iconic Webb image.
    It is being presented today at a special event hosted by the International Planetarium Society to commemorate the 100th anniversary of the first public planetarium in Munich, Germany.
    The landscape of “mountains” and “valleys” known as the Cosmic Cliffs is actually a portion of the nebula Gum 31, which contains a young star cluster called NGC 3324. Both Gum 31 and NGC 3324 are part of a vast star-forming region known as the Carina Nebula Complex.
    Ultraviolet light and stellar winds from the stars of NGC 3324 have carved a cavernous area within Gum 31. A portion of this giant bubble is seen above the Cosmic Cliffs. (The star cluster itself is outside this field of view.)
    The Cliffs display a misty appearance, with “steam” that seems to rise from the celestial mountains. In actuality, the wisps are hot, ionized gas and dust streaming away from the nebula under an onslaught of relentless ultraviolet radiation.
    Eagle-eyed viewers may also spot particularly bright, yellow streaks and arcs that represent outflows from young, still-forming stars embedded within the Cosmic Cliffs. The latter part of the visualization sequence swoops past a prominent protostellar jet in the upper right of the image.

    [embedded content]
    In July 2022, NASA’s James Webb Space Telescope made history, revealing a breathtaking view of a region now nicknamed the Cosmic Cliffs.This glittering landscape, captured in incredible detail, is part of the nebula Gum 31 — a small piece of the vast Carina Nebula Complex — where stars are born amid clouds of gas and dust.This visualization brings Webb’s iconic image to life — helping us imagine the true, three-dimensional structure of the universe… and our place within it.

    Produced for NASA by the Space Telescope Science Institute (STScI) with partners at Caltech/IPAC, and developed by the AstroViz Project of NASA’s Universe of Learning, this visualization is part of a longer, narrated video that provides broad audiences, including youth, families, and lifelong learners, with a direct connection to the science and scientists of NASA’s Astrophysics missions. That video enables viewers to explore fundamental questions in science, experience how science is done, and discover the universe for themselves.
    “Bringing this amazing Webb image to life helps the public to comprehend the three-dimensional structure inherent in the 2D image, and to develop a better mental model of the universe,” said STScI’s Frank Summers, principal visualization scientist and leader of the AstroViz Project.
    More visualizations and connections between the science of nebulas and learners can be explored through other products produced by NASA’s Universe of Learning including a Carina Nebula Complex resource page and ViewSpace, a video exhibit that is currently running at almost 200 museums and planetariums across the United States. Visitors can go beyond video to explore the images produced by space telescopes with interactive tools now available for museums and planetariums.
    NASA’s Universe of Learning materials are based upon work supported by NASA under award number NNX16AC65A to the Space Telescope Science Institute, working in partnership with Caltech/IPAC, Center for Astrophysics | Harvard & Smithsonian, and NASA’s Jet Propulsion Laboratory.
    The James Webb Space Telescope is the world’s premier space science observatory. Webb is solving mysteries in our solar system, looking beyond to distant worlds around other stars, and probing the mysterious structures and origins of our universe and our place in it. Webb is an international program led by NASA with its partners, ESA (European Space Agency) and CSA (Canadian Space Agency).
    NASA’s Universe of Learning is part of the NASA Science Activation program, from the Science Mission Directorate at NASA Headquarters. The Science Activation program connects NASA science experts, real content and experiences, and community leaders in a way that activates minds and promotes deeper understanding of our world and beyond. Using its direct connection to the science and the experts behind the science, NASA’s Universe of Learning provides resources and experiences that enable youth, families, and lifelong learners to explore fundamental questions in science, experience how science is done, and discover the universe for themselves.
    To learn more about Webb, visit:
    https://science.nasa.gov/webb
    Downloads
    View/Download all image products at all resolutions for this article from the Space Telescope Science Institute.

    Laura Betz – laura.e.betz@nasa.govNASA’s Goddard Space Flight Center, Greenbelt, Md.
    Christine Pulliam – cpulliam@stsci.eduSpace Telescope Science Institute, Baltimore, Md.

    Explore more: Carina Nebula Complex from NASA’s Universe of Learning
    Read more: Webb’s view of the Cosmic Cliffs
    Listen: Carina Nebula sonification
    Read more: Webb’s star formation discoveries
    More Webb News
    More Webb Images
    Webb Science Themes
    Webb Mission Page

    What is the Webb Telescope?
    SpacePlace for Kids
    En Español
    Ciencia de la NASA
    NASA en español 
    Space Place para niños

    MIL OSI USA News –

  • MIL-OSI USA: NASA Statement on Appointment of New JPL Director

    Source: NASA

    The following is a statement from acting NASA Administrator Janet Petro on the appointment of David Gallagher as director of the agency’s Jet Propulsion Laboratory (JPL) in Southern California. NASA JPL announced Wednesday Laurie Leshin would step down effective Sunday, June 1.
    “Laurie Leshin’s leadership at JPL has been nothing short of extraordinary. She brought a sharp scientific mind, a strong sense purpose, and a clear vision that helped propel the lab forward during a pivotal time. From groundbreaking missions to remarkable technological milestones, Laurie advanced JPL’s legacy of exploration and innovation. We are grateful for her service and wish her the very best as she continues to inspire in the next phase of her career.
    “I’m equally confident in Dave Gallagher’s ability to lead JPL’s next chapter. He brings decades of experience, a steady hand, and a deep understanding of what makes JPL unique. With Dave at the helm, JPL remains well-positioned to continue delivering for NASA and the nation – pushing the boundaries of science and discovery for the benefit of all.”
    For more information about NASA, visit:

    Home Page

    -end-
    Bethany Stevens / Amber JacobsonHeadquarters, Washington202-358-1600bethany.c.stevens@nasa.gov / amber.c.jacobson@nasa.gov 

    MIL OSI USA News –

  • MIL-OSI USA: Dave Gallagher Named 11th Director of JPL as Laurie Leshin Steps Down

    Source: NASA

    Laurie Leshin has decided to step down as director of NASA’s Jet Propulsion Laboratory on Sunday, June 1. David Gallagher, who has been serving as the Lab’s associate director for Strategic Integration, has been selected by Caltech to lead the federally funded research and development center. Caltech manages JPL for NASA.
    A distinguished geochemist, Leshin was named by Caltech to lead the lab in early 2022. Her career has spanned academia and senior positions at NASA. Several NASA missions managed by JPL have launched under her leadership, including EMIT, SWOT, Psyche, PREFIRE, Europa Clipper, and SPHEREx, with the NASA-Indian Earth satellite NISAR set for a June launch. In addition, JPL has advanced the development of NASA’s asteroid-hunting NEO Surveyor mission as well as the trio of CADRE lunar rovers, and it delivered the Coronagraph Instrument, a technology demonstration with NASA’s forthcoming Roman Space Telescope.
    “I am proud of the many things JPL has accomplished over the past three years,” said Leshin. “In addition to the long list of missions that have launched or moved toward launch during that time, we saved Voyager more than once and flew into history on Mars with Ingenuity. We have made more amazing scientific discoveries than I can name, including finding potential ancient Martian biomarkers with Perseverance. And we’ve driven the forefront of technology on Earth and in space. I know those achievements will continue under Dave’s capable leadership.”
    Leshin, who has also served as Caltech vice president, is stepping down for personal reasons and will remain a Bren Professor of Geochemistry and Planetary Science at Caltech.
    “While we respect Laurie’s decision to step away from her leadership position at JPL, we will miss her drive, compassion, and dedication,” Caltech President Thomas Rosenbaum said. “At the same time, we are grateful to Dave Gallagher for his devotion to JPL and his continuing leadership and partnership going forward. Dave’s experience working across multiple government and private sector entities will help secure ongoing support for America’s agenda in space, with JPL continuing to play an essential role.”
    Gallagher will draw on his deep experience at JPL to lead the lab into the future. He arrived at JPL 36 years ago, in 1989, and went on to hold numerous leadership positions. Along with having served as the director and deputy director for Astronomy, Physics, and Space Technology, he was manager of JPL’s Advanced Optical Systems Program Office. An electrical engineer, Gallagher also managed the Spitzer Space Telescope and, among other roles, led the team that built and tested the Wide Field/Planetary Camera 2 (WF/PC-2) — a critical instrument that corrected the spherical aberration on NASA’s Hubble Space Telescope.
    “Laurie has made a significant impact on energizing and focusing the lab, guiding it back on track after the Covid-19 pandemic. I wish her great success in this next chapter of her career, and I look forward to a very smooth transition at the lab,” said Gallagher. “We have exciting opportunities ahead helping to advance our nation’s space agenda and a fantastic team to help realize them.”
    Founded by Caltech faculty and students in 1936, JPL has been managed by Caltech on behalf of NASA since 1958.
    News Media Contacts
    Matthew Segal / Veronica McGregorJet Propulsion Laboratory, Pasadena, Calif.818-354-8307 / 818-354-9452matthew.j.segal@jpl.nasa.gov / veronica.c.mcgregor@jpl.nasa.gov

    MIL OSI USA News –

  • MIL-OSI USA: NASA Expands Youth Engagement With New Scouting America Agreement

    Source: NASA

    NASA and the Sam Houston Area Council (SHAC) of Scouting America signed a collaborative Space Act Agreement on December 17, 2024, expanding youth access to programs and opportunities with the Johnson Space Center’s Office of STEM Engagement (OSTEM) in Houston.
    The agreement forges the first formal partnership between NASA OSTEM and Scouting America. It will leverage NASA’s educational outreach programs to enrich scout activities and experiences while providing the agency with new opportunities to engage youth around its mission, vision, and goals.

    “Our ability to explore the unknown and innovate for the benefit of all humanity depends on a highly skilled and competitive STEM workforce,” said NASA Acting Associate Administrator Vanessa Wyche. “Together with SHAC, we can inspire future generations of explorers, scientists, and engineers to help us take the next giant leap toward exciting discoveries.”
    The agreement has already enabled NASA and SHAC to collaborate on a new space-focused summer experience at Camp Strake, the council’s premier camping facility in Southeast Texas. During the weeklong program, scouts will participate in hands-on STEM activities created in partnership with NASA, tour Johnson Space Center, attend robotics and space exploration workshops, and get an in-depth look at NASA’s current projects. SHAC serves approximately 25,000 youth in 16 counties in Southeast Texas.

    “NASA and SHAC share common goals of growing youth interest in science, technology, engineering, and math careers, and providing access to programs and experiences that prepare them to enter the STEM workforce,” said Gamaliel Cherry, director of Johnson’s Office of STEM Engagement. “We are excited to connect more students to NASA’s mission, work, and people through this partnership.”
    NASA OSTEM provides opportunities for the next generation of explorers to discover and hone the science, technology, engineering, and math skills needed for the agency’s bold exploration plans.
    For the latest NASA STEM events, news, and activities for students at any grade level, visit:
    https://stem.nasa.gov

    MIL OSI USA News –

  • MIL-OSI USA: NASA Selects Winners of the 2024-2025 Power to Explore Challenge

    Source: NASA

    Explore This Section

    RPS Home
    About

    About RPS
    About the Program
    About Plutonium-238
    Safety and Reliability
    For Mission Planners
    Contact

    Power & Heat

    Overview
    Power Systems
    Thermal Systems
    Dynamic Radioisotope Power

    Missions

    Overview
    Timeline

    News
    Resources
    STEM
    FAQ

    3 min read
    NASA Selects Winners of the 2024-2025 Power to Explore Challenge

    Ten-year-old, Terry Xu of Arcadia, California; 14-year-old, Maggie Hou of Snohomish, Washington; and 17-year-old, Kairat Otorov of Trumbull, Connecticut, winners of the 2024-2025 Power to Explore Student Writing Challenge.
    NASA/David Lam, Binbin Zheng, The Herald/Olivia Vanni, Meerim Otorova

    NASA has chosen three winners out of nine finalists in the fourth annual Power to Explore Challenge, a national writing competition designed to teach K-12 students about the enabling power of radioisotopes for space exploration.

    “Congratulations to the amazing champions and all of the participants!

    Carl Sandifer II
    Program Manager, NASA’s Radioisotope Power Systems Program

    The essay competition asked students to learn about NASA’s radioisotope power systems (RPS), likened to “nuclear batteries,” which the agency has used discover “moonquakes” on Earth’s Moon and study some of the most extreme of the more than 891 moons in the solar system. In 275 words or less, students dreamed up a unique exploration mission of one of these moons and described their own power to achieve their mission goals.
    “I’m so impressed by the creativity and knowledge of our Power to Explore winners,” said Carl Sandifer II, program manager of the Radioisotope Power Systems Program at NASA’s Glenn Research Center in Cleveland.
    Entries were split into three groups based on grade level, and a winner was chosen from each. The three winners, each accompanied by a guardian, are invited to NASA’s Glenn Research Center in Cleveland for a VIP tour of its world-class research facilities this summer.
    The winners are:

    Terry Xu, Arcadia, California, kindergarten through fourth grade
    Maggie Hou, Snohomish, Washington, fifth through eighth grade
    Kairat Otorov, Trumbull, Connecticut, ninth through 12th grade

    “Congratulations to the amazing champions and all of the participants! Your “super powers” inspire me and make me even more optimistic about the future of America’s leadership in space,” Sandifer said.
    The Power to Explore Challenge offered students the opportunity to learn about space power, celebrate their own strengths, and interact with NASA’s diverse workforce. This year’s contest received nearly 2,051 submitted entries from all 50 states, U.S. territories, and the Department of Defense Education Activity overseas.
    Every student who submitted an entry received a digital certificate and an invitation to the Power Up virtual event held on March 21. There, NASA announced the 45 national semifinalists, and students learned about what powers the NASA workforce.
    Additionally, the national semifinalists received a NASA RPS prize pack.
    NASA announced three finalists in each age group (nine total) on April 23. Finalists were invited to discuss their mission concepts with a NASA scientist or engineer during an exclusive virtual event.
    The challenge is funded by the Radioisotope Power Systems Program Office in NASA’s Science Mission Directorate and administered by Future Engineers under a Small Business Innovation Research phase III contract. This task is managed by the NASA Tournament Lab, a part of the Prizes, Challenges, and Crowdsourcing Program in NASA’s Space Technology Mission Directorate.
    For more information on radioisotope power systems visit: https://nasa.gov/rps

    Karen Fox / Erin Morton
    Headquarters, Washington
    301-286-6284 / 202-805-9393
    karen.c.fox@nasa.gov / erin.morton@nasa.gov

    Kristin Jansen
    Glenn Research Center, Cleveland
    216-296-2203
    kristin.m.jansen@nasa.gov

    MIL OSI USA News –

  • MIL-OSI Video: Yemen, Sudan, Occupied Palestinian Territory & other topics – Daily Press Briefing (7 May 2025)

    Source: United Nations (Video News)

    Noon briefing by Stephanie Tremblay, Associate Spokesperson for the Secretary-General.

    Highlights:
    Secretary-General’s Travel
    Yemen
    Sudan
    Occupied Palestinian Territory
    Ukraine
    Haiti
    Security Council
    Science, Technology and Innovation Forum

    SECRETARY-GENERAL’S TRAVEL
    The Secretary-General is Denmark today, where tomorrow he will chair the meeting of the Chief Executives Board of the United Nations which brings together the heads of the UN system. 
    Earlier today, the Secretary-General met with Ms. Mette Frederiksen, Prime Minister of Denmark. The Secretary-General expressed appreciation for Denmark’s steadfast cooperation with and support for the United Nations, including for its role as host of UN agencies as well as its constructive role as a non-permanent member of the Security Council.
    The Secretary-General expressed appreciation for Denmark’s steadfast cooperation, as well as its constructive role as a non-permanent member of the Security Council. 
    Prior to meeting the Prime Minister, the Secretary-General toured UN City, the compound in Copenhagen that houses United Nations offices in the Danish capital. During a townhall meeting, the Secretary-General congratulated the staff for the work they are doing. 
    This evening, the Secretary-General and the heads of the United Nations system are attending a welcome diner hosted by the King and Queen of Denmark.

    YEMEN
    The UN welcomes the announcement made by the Sultanate of Oman regarding an agreement between the United States and the Houthis in Yemen on 6 May, and commend Oman for its efforts in this regard.
    The UN had consistently called for restraint and de-escalation in and around Yemen and the wider region. We also have called for an immediate cessation of Houthi attacks against merchant and commercial vessels in line with relevant Security Council resolutions. We reaffirm the need for all to respect the rights and obligations relating to maritime navigation in accordance with international law. We remain committed to supporting the Yemeni parties to reach a negotiated political settlement to end the conflict.
    The UN encourages all parties to engage constructively with UN Special Envoy Hans Grundberg to this end.

    SUDAN
    Moving to Sudan, the Under-Secretary-General for Humanitarian Affairs, Tom Fletcher, expressed deep concern over the ongoing drone strikes in Port Sudan, which is a hub for our humanitarian operations and key entry point for aid.
    Mr. Fletcher stressed that international humanitarian law must be respected and that constant care must be taken to spare civilians and civilian infrastructure.
    Flights of the UN Humanitarian Air Services – or UNHAS – to and from Port Sudan have been suspended since May 4th. The World Food Programme, which manages UNHAS, says it will resume air operations as soon as conditions allow.
    These disruptions are impacting the movement of humanitarian personnel into Sudan and onward to other parts of the country, further straining the delivery of urgently needed assistance. Meanwhile, OCHA reports that drone attacks have also affected the states of Kassala and River Nile. Earlier this week in Kassala, strikes near the airport displaced about 2,900 people and led to the temporary suspension or relocation of some aid activities.
    Meanwhile, River Nile State is still facing a power blackout following a drone strike on the transformer station in Atbara on April 25th. The outage is contributing to growing fuel and bread shortages and long queues at petrol stations and bakeries.

    OCCUPIED PALESTINIAN TERRITORY
    Turning to the situation in Gaza, our colleagues from the Office for the Coordination of Humanitarian Affairs warn that the situation there is growing worse by the day. Yet we and our partners are committed to staying and delivering to help alleviate the suffering of the people exhausted by many months of fighting.
    Attacks on schools sheltering displaced people continue to be reported, leading to casualties. Yesterday in Deir al Balah, an UNRWA school in Al Bureij camp was hit twice in several hours, with dozens of people reportedly killed, including women and children. Another school in Gaza city sheltering displaced people was also struck yesterday, with reports that 20 people were killed.
    Across Gaza, community kitchens serving hot meals continue to shut down, as they use up their last remaining supplies. As of yesterday, one in every three community kitchens supported by the UN and our partners in Gaza has closed.

    Full highlights: https://www.un.org/sg/en/content/noon-briefing-highlight?date%5Bvalue%5D%5Bdate%5D=07%20May%202025

    https://www.youtube.com/watch?v=N4A1_sSsDPg

    MIL OSI Video –